Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS20040122353 A1
Publication typeApplication
Application numberUS 10/335,256
Publication dateJun 24, 2004
Filing dateDec 31, 2002
Priority dateDec 19, 2002
Also published asUS8622954, US20100280442
Publication number10335256, 335256, US 2004/0122353 A1, US 2004/122353 A1, US 20040122353 A1, US 20040122353A1, US 2004122353 A1, US 2004122353A1, US-A1-20040122353, US-A1-2004122353, US2004/0122353A1, US2004/122353A1, US20040122353 A1, US20040122353A1, US2004122353 A1, US2004122353A1
InventorsVaraz Shahmirian, Wayne Morgan, Sheldon Moberg, Cary Talbot, Arthur Campbell, Jay Yonemoto
Original AssigneeMedtronic Minimed, Inc.
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Relay device for transferring information between a sensor system and a fluid delivery system
US 20040122353 A1
Abstract
A relay device transfers information between a sensor system, which measures a physiological characteristic level of a user, and a fluid delivery system, which infuses a fluid into a user. The relay device includes a sensor system receiver for receiving communications from the sensor system in a sensor system format. The relay device also includes a processor for processing the communications from the sensor system and converting the communications for transmission in a delivery system format. The relay device further includes a delivery system transmitter for transmitting the converted communications in the delivery system format to the fluid delivery system. The sensor system and delivery system formats may utilize different frequencies and/or different communication protocols for communications transmitted between the sensor system and the fluid delivery system through the relay device.
Images(21)
Previous page
Next page
Claims(96)
What is claimed is:
1. An infusion system for infusing a fluid into a user, the infusion system comprising:
a sensor system including:
a sensor system housing;
a sensor coupled to the sensor system housing for producing a signal indicative of a physiological characteristic level of the user;
a sensor system processor contained in the sensor system housing for processing the signal indicative of the physiological characteristic level of the user; and
a sensor system transmitter contained in the sensor system housing and coupled to the sensor system processor for transmitting one or more communications in a sensor system format;
a relay device including:
a relay device receiver for receiving the communications from the sensor system in the sensor system format;
a relay device processor for processing the communications from the sensor system and converting the communications for transmission in a delivery system format; and
a relay device transmitter for transmitting the converted communications in the delivery system format; and
a fluid delivery system including:
a delivery system housing;
a delivery system receiver contained in the delivery system housing for receiving the communications from the relay device in the delivery system format; and
a delivery system processor contained in the delivery system housing and coupled to the delivery system receiver for processing the communications from the relay device in the delivery system format and controlling an amount of the fluid infused into the user;
wherein the amount of the fluid infused into the user is determined based upon data indicative of the physiological characteristic level of the user obtained by the sensor system.
2. The infusion system according to claim 1, wherein at least one of the communications transmitted from the sensor system through the relay device and received by the fluid delivery system include data indicative of the physiological characteristic level of the user.
3. The infusion system according to claim 2, wherein the communications including the data indicative of the physiological characteristic level of the user are automatically transmitted from the sensor system through the relay device and received by the fluid delivery system.
4. The infusion system according to claim 3, wherein the fluid delivery system further includes a display device contained in the delivery system housing and coupled to the delivery system processor for automatically displaying to the user the data indicative of the physiological characteristic level of the user.
5. The infusion system according to claim 3, wherein the fluid delivery system further includes:
a display device contained in the delivery system housing and coupled to the delivery system processor for displaying data to the user; and
a user interface contained in the delivery system housing and coupled to the delivery system processor for accepting one or more inputs from the user, wherein at least one of the inputs causes the display device to display the data indicative of the physiological characteristic level of the user received by the fluid delivery system.
6. The infusion system according to claim 5, wherein at least a portion of the user interface is dedicated for interfacing with the data indicative of the physiological characteristic level of the user received by the fluid delivery system.
7. The infusion system according to claim 3, wherein the fluid delivery system further includes a memory contained in the delivery system housing for storing the data indicative of the physiological characteristic level of the user received by the fluid delivery system.
8. The infusion system according to claim 7, wherein the fluid delivery system further includes a display device contained in the delivery system housing and coupled to the delivery system processor for displaying to the user a historical trend or graph using the stored data indicative of the physiological characteristic level of the user received by the fluid delivery system.
9. The infusion system according to claim 7, wherein the fluid delivery system further includes:
a display device contained in the delivery system housing and coupled to the delivery system processor for displaying data to the user; and
a user interface contained in the delivery system housing and coupled to the delivery system processor for accepting one or more inputs from the user, wherein at least one of the inputs causes the display device to display the most recent data indicative of the physiological characteristic level of the user received by the fluid delivery system.
10. The infusion system according to claim 9, wherein at least another one of the inputs causes the display device to display the next most recent data indicative of the physiological characteristic level of the user received by the fluid delivery system.
11. The infusion system according to claim 9, wherein at least a portion of the user interface is dedicated for interfacing with the data indicative of the physiological characteristic level of the user received by the fluid delivery system.
12. The infusion system according to claim 9, wherein at least another one of the inputs causes the display device to display the stored data that is older than the most recent data indicative of the physiological characteristic level of the user received by the fluid delivery system.
13. The infusion system according to claim 2, wherein the fluid delivery system further includes:
a display device contained in the delivery system housing and coupled to the delivery system processor for displaying data to the user; and
a user interface contained in the delivery system housing and coupled to the delivery system processor for accepting one or more inputs from the user, wherein at least one of the inputs causes the display device to display the data indicative of the physiological characteristic level of the user received by the fluid delivery system.
14. The infusion system according to claim 13, wherein at least a portion of the user interface is dedicated for interfacing with the data indicative of the physiological characteristic level of the user received by the fluid delivery system.
15. The infusion system according to claim 2, wherein the fluid delivery system further includes a user interface contained in the delivery system housing and coupled to the delivery system processor for accepting one or more inputs from the user, wherein at least one of the inputs programs the amount of the fluid infused into the user based upon the data indicative of the physiological characteristic level of the user received by the fluid delivery system.
16. The infusion system according to claim 2, wherein the fluid delivery system further includes:
a bolus estimator used in conjunction with the delivery system processor for estimating the amount of the fluid to be infused into the user based upon the data indicative of the physiological characteristic level of the user received by the fluid delivery system;
an indication device coupled to the bolus estimator for indicating the estimated amount of fluid to be infused into the user; and
a user interface for accepting one or more inputs from the user, wherein at least one of the inputs accepts or modifies the estimated amount of the fluid to be infused into the user.
17. The infusion system according to claim 2, wherein the fluid delivery system further includes a closed loop algorithm executed by the delivery system processor for automatically determining the amount of the fluid to be infused into the user based upon the data indicative of the physiological characteristic level of the user received by the fluid delivery system and causing the fluid delivery system to infuse the determined amount of the fluid into the user.
18. The infusion system according to claim 2, wherein the fluid delivery system further includes an indication device for indicating when the data indicative of the physiological characteristic level of the user received by the fluid delivery system is above or below a target characteristic value.
19. The infusion system according to claim 2, wherein the fluid delivery system further includes:
a delivery system transmitter contained in the delivery system housing and coupled to the delivery system processor for transmitting one or more communications in the delivery system format,
wherein the relay device receiver further receives the communications from the fluid delivery system in the delivery system format, the relay device processor processes the communications from the fluid delivery system and converts the communications for transmission in the sensor system format, and the relay device transmitter transmits the converted communications in the sensor system format, and
wherein the sensor system further includes a sensor system receiver contained in the sensor system housing and coupled to the sensor system processor for receiving the communications from the relay device in the sensor system format.
20. The infusion system according to claim 19, wherein the fluid delivery system further includes:
a display device contained in the delivery system housing and coupled to the delivery system processor for displaying data to the user; and
a user interface contained in the delivery system housing and coupled to the delivery system processor for accepting one or more inputs from the user, wherein at least one of the inputs generates a request for the data indicative of the physiological characteristic level of the user from the sensor system,
wherein at least one of the communications transmitted from the fluid delivery system through the relay device to the sensor system includes the request,
wherein at least one of the communications including the data indicative of the physiological characteristic level of the user is transmitted from the sensor system through the relay device and received by the delivery system in response to the request, and
wherein the display device displays the data indicative of the physiological characteristic level of the user received by the fluid delivery system.
21. The infusion system according to claim 20, wherein at least a portion of the user interface is dedicated for interfacing from the fluid delivery system with the sensor system through the relay device.
22. The infusion system according to claim 20, wherein the requested data is the most recent data indicative of the physiological characteristic level of the user received by the fluid delivery system.
23. The infusion system according to claim 20, wherein the fluid delivery system further includes a memory contained in the delivery system housing for storing the data indicative of the physiological characteristic level of the user received by the fluid delivery system.
24. The infusion system according to claim 23, wherein at least another one of the inputs causes the display device to display a historical trend or graph using the stored data indicative of the physiological characteristic level of the user received by the fluid delivery system.
25. The infusion system according to claim 2, wherein the data indicative of the physiological characteristic level of the user received by the fluid delivery system is uncalibrated data, and the fluid delivery system further includes a calibration algorithm executed by the delivery system processor for calibrating the uncalibrated data to generate one or more measurements indicative of the physiological characteristic level of the user.
26. The infusion system according to claim 2, wherein the data indicative of the physiological characteristic level of the user received by the fluid delivery system includes one or more measurements indicative of the physiological characteristic level of the user.
27. The infusion system according to claim 26, wherein the sensor system further includes a calibration algorithm executed by the sensor system processor for calibrating the signal indicative of the physiological characteristic level of the user to generate the one or more measurements indicative of the physiological characteristic level of the user, and the communications transmitted from the sensor system through the relay device and received by the fluid delivery system include the one or more measurements indicative of the physiological characteristic level of the user.
28. The infusion system according to claim 26, wherein the data indicative of the physiological characteristic level of the user received from the sensor system by the relay device is uncalibrated data, and the relay device further includes a calibration algorithm executed by the relay device processor for calibrating the uncalibrated data to generate one or more measurements indicative of the physiological characteristic level of the user, wherein the communications transmitted from the relay device and received by the fluid delivery system include the one or more measurements indicative of the physiological characteristic level of the user.
29. The infusion system according to claim 2, wherein the data indicative of the physiological characteristic level of the user received by the fluid delivery system is downloadable to an external storage device.
30. The infusion system according to claim 2, wherein the fluid delivery system further includes a memory contained in the delivery system housing for storing the data indicative of the physiological characteristic level of the user received by the fluid delivery system.
31. The infusion system according to claim 1, wherein at least one of the communications transmitted from the sensor system through the relay device and received by the delivery system includes one or more commands for programming the amount of the fluid infused into the user based upon the data indicative of the physiological characteristic level of the user.
32. The infusion system according to claim 31, wherein the sensor system further includes:
a display device coupled to the sensor system processor for displaying data to the user; and
a user interface coupled to the sensor system processor for accepting one or more inputs from the user, wherein at least one of the inputs causes the display device to display the data indicative of the physiological characteristic level of the user obtained by the sensor system.
33. The infusion system according to claim 32, wherein at least another one of the inputs generates the one or more commands for programming the amount of the fluid infused into the user based upon the data indicative of the physiological characteristic level of the user obtained by the sensor system.
34. The infusion system according to claim 31, wherein the sensor system further includes a closed loop algorithm executed by the sensor system processor for automatically generating the one or more commands for programming the amount of the fluid to be infused into the user based upon the data indicative of the physiological characteristic level of the user obtained by the sensor system.
35. The infusion system according to claim 1, wherein at least one of the communications transmitted from the sensor system to the relay device includes the data indicative of the physiological characteristic level of the user, and at least one of the communications transmitted from the relay device and received by the fluid delivery system includes one or more commands for programming the amount of the fluid infused into the user based upon the data indicative of the physiological characteristic level of the user.
36. The infusion system according to claim 35, wherein the relay device further includes:
a display device coupled to the relay device processor for displaying data to the user; and
a user interface coupled to the relay device processor for accepting one or more inputs from the user, wherein at least one of the inputs causes the display device to display the data indicative of the physiological characteristic level of the user obtained by the sensor system.
37. The infusion system according to claim 36, wherein at least another one of the inputs generates the one or more commands for programming the amount of the fluid infused into the user based upon the data indicative of the physiological characteristic level of the user obtained by the sensor system.
38. The infusion system according to claim 35, wherein the relay device further includes a closed loop algorithm executed by the relay device processor for automatically generating the one or more commands for programming the amount of the fluid to be infused into the user based upon the data indicative of the physiological characteristic level of the user obtained by the sensor system.
39. The infusion system according to claim 1, wherein the sensor system format and the delivery system format utilize different frequencies for communications transmitted from the sensor system through the relay device and received by the fluid delivery system.
40. The infusion system according to claim 1, wherein the sensor system format and the delivery system format utilize different communication protocols for communications transmitted from the sensor system through the device and received by the fluid delivery system.
41. The infusion system according to claim 40, wherein the different communication protocols utilize different carrier media for communications transmitted from the sensor system through the relay device and received by the fluid delivery system.
42. The infusion system according to claim 40, wherein the different communication protocols utilize different information packaging for communications transmitted from the sensor system through the relay device and received by the fluid delivery system.
43. The infusion system according to claim 1, wherein the communications transmitted from the sensor system through the relay device and received by the fluid delivery system are transmitted using radio frequency communication.
44. The infusion system according to claim 1, wherein the communications transmitted from the sensor system through the relay device and received by the fluid delivery system are transmitted using infrared communication.
45. The infusion system according to claim 1, wherein the delivery system processor has a unique identification code, and the sensor system processor has the capability to learn the unique identification code of the delivery system processor, and further wherein the communications transmitted from the sensor system through the relay device and received by the fluid delivery system include the unique identification code of the delivery system processor to substantially avoid interference with other devices.
46. The infusion system according to claim 1, wherein the sensor system processor has a unique identification code, and the delivery system processor has the capability to learn the unique identification code of the sensor system processor, and further wherein the communications transmitted from the sensor system through the relay device and received by the fluid delivery system include the unique identification code of the sensor system processor to substantially avoid interference with other devices.
47. The infusion system according to claim 1, wherein the relay device processor has a unique identification code, and the sensor system processor has the capability to learn the unique identification code of the relay device processor, and further wherein the communications transmitted from the sensor system to the relay device include the unique identification code of the relay device processor to substantially avoid interference with other devices.
48. The infusion system according to claim 1, wherein the relay device processor has a unique identification code, and the delivery system processor has the capability to learn the unique identification code of the relay device processor, and further wherein the communications transmitted from the relay device and received by the fluid delivery system include the unique identification code of the relay device processor to substantially avoid interference with other devices.
49. The infusion system according to claim 1, wherein the relay device is coupled to the delivery system housing.
50. The infusion system according to claim 1, wherein the relay device is contained in the delivery system housing.
51. The infusion system according to claim 1, wherein the relay device is coupled to the sensor system housing.
52. The infusion system according to claim 1, wherein the sensor system is a glucose monitoring system, and the fluid delivery system is an insulin infusion device.
53. A relay device for transferring information between a sensor system and a fluid delivery system, wherein the sensor system measures a physiological characteristic level of a user, and the fluid delivery system infuses a fluid into the user, the relay device comprising:
a sensor system receiver for receiving one or more communications from the sensor system in a sensor system format;
a processor for processing the communications from the sensor system and converting the communications for transmission in a delivery system format; and
a delivery system transmitter for transmitting the converted communications in the delivery system format to the fluid delivery system.
54. The relay according to claim 53, further comprising:
a delivery system receiver for receiving one or more communications from the fluid delivery system in the delivery system format, wherein the processor further processes the communications from the fluid delivery system and converts the communications for transmission in the sensor system format; and
a sensor system transmitter for transmitting the converted communications in the sensor system format to the sensor system.
55. The relay device according to claim 53, wherein at least one of the communications transmitted from the sensor system through the relay device and received by the fluid delivery system include data indicative of the physiological characteristic level of the user.
56. The relay device according to claim 53, wherein at least one of the communications transmitted from the sensor system through the relay device and received by the delivery system includes one or more commands for programming an amount of the fluid to be infused into the user based upon data indicative of the physiological characteristic level of the user obtained by the sensor system.
57. The relay device according to claim 53, wherein at least one of the communications transmitted from the sensor system to the relay device includes data indicative of the physiological characteristic level of the user, and at least one of the communications transmitted from the relay device and received by the fluid delivery system includes one or more commands for programming an amount of the fluid to be infused into the user based upon the data indicative of the physiological characteristic level of the user.
58. The relay device according to claim 57, wherein the relay device further includes:
a display device coupled to the processor for displaying data to the user; and
a user interface coupled to the processor for accepting one or more inputs from the user, wherein at least one of the inputs causes the display device to display the data indicative of the physiological characteristic level of the user.
59. The relay device according to claim 58, wherein at least another one of the inputs generates the one or more commands for programming the amount of the fluid to be infused into the user based upon the data indicative of the physiological characteristic level of the user.
60. The relay device according to claim 53, wherein the sensor system format and the delivery system format utilize different frequencies for communications transmitted from the sensor system through the relay device to the fluid delivery system.
61. The relay device according to claim 53, wherein the sensor system format and the delivery system format utilize different communication protocols for communications transmitted from the sensor system through the relay device to the fluid delivery system.
62. The relay device according to claim 61, wherein the different communication protocols utilize different carrier media for communications transmitted from the sensor system through the relay device to the fluid delivery system.
63. The relay device according to claim 61, wherein the different communication protocols utilize different information packaging for communications transmitted from the sensor system through the relay device to the fluid delivery system.
64. A relay device for transferring information between a sensor system and a fluid delivery system, wherein the sensor system measures a physiological characteristic level of a user, and the fluid delivery system infuses a fluid into the user, the device comprising:
a sensor system transceiver for transmitting and receiving one or more communications to and from the sensor system, wherein the communications are transmitted and received in a sensor system format;
a delivery system transceiver for transmitting and receiving one or more communications to and from the fluid delivery system, wherein the communications are transmitted and received in a delivery system format;
a processor for processing the communications from the sensor system and the fluid delivery system, wherein the processor converts the communications received from the sensor system in the sensor system format for transmission in the delivery system format to the fluid delivery system, and further wherein the processor converts the communications received from the fluid delivery system in the delivery system format for transmission in the sensor system format to the sensor system.
65. The relay device according to claim 64, wherein at least one of the communications transmitted from the sensor system through the relay device and received by the fluid delivery system include data indicative of the physiological characteristic level of the user.
66. The relay device according to claim 64, wherein at least one of the communications transmitted from the sensor system through the relay device and received by the fluid delivery system includes one or more commands for programming an amount of the fluid to be infused into the user based upon data indicative of the physiological characteristic level of the user obtained by the sensor system.
67. The relay device according to claim 64, wherein at least one of the communications transmitted from the sensor system to the relay device includes data indicative of the physiological characteristic level of the user, and at least one of the communications transmitted from the relay device and received by the fluid delivery system includes one or more commands for programming an amount of the fluid to be infused into the user based upon the data indicative of the physiological characteristic level of the user.
68. The relay device according to claim 67, wherein the relay device further includes:
a display device coupled to the processor for displaying data to the user; and
a user interface coupled to the processor for accepting one or more inputs from the user, wherein at least one of the inputs causes the display device to display the data indicative of the physiological characteristic level of the user.
69. The relay device according to claim 68, wherein at least another one of the inputs generates the one or more commands the for programming amount of the fluid to be infused into the user based upon the data indicative of the physiological characteristic level of the user.
70. The relay device according to claim 64, wherein the sensor system format and the delivery system format utilize different frequencies for communications transmitted between the sensor system and the fluid delivery system through the relay device.
71. The relay device according to claim 64, wherein the sensor system format and the delivery system format utilize different communication protocols for communications transmitted between the sensor system and the fluid delivery system through the relay device.
72. The relay device according to claim 71, wherein the different communication protocols utilize different carrier media for communications transmitted between the sensor system and the fluid delivery system through the relay device.
73. The relay device according to claim 71, wherein the different communication protocols utilize different information packaging for communications transmitted between the sensor system and the fluid delivery system through the relay device.
74. An infusion system for infusing a fluid into a user, the infusion system comprising:
a sensor system including:
a sensor for producing a signal indicative of a physiological characteristic level of the user;
a sensor system processor coupled to the sensor for processing the signal indicative of the physiological characteristic level of the user; and
a sensor system transmitter coupled to the sensor system processor for transmitting one or more communications in a sensor system format; and
a fluid delivery system including:
a delivery system housing;
a relay device contained in the delivery system housing, the relay device including:
a relay device receiver for receiving the communications from the sensor system in the sensor system format;
a relay device processor for processing the communications from the sensor system and converting the communications for transmission in a delivery system format; and
a relay device transmitter for transmitting the converted communications in the delivery system format;
a delivery system receiver contained in the delivery system housing for receiving the communications from the relay device in the delivery system format; and
a delivery system processor contained in the delivery system housing and coupled to the delivery system receiver for processing the communications from the relay device in the delivery system format and controlling an amount of the fluid infused into the user;
wherein the amount of the fluid infused into the user is determined based upon data indicative of the physiological characteristic level of the user obtained by the sensor system.
75. The infusion system according to claim 74, wherein at least one of the communications transmitted from the sensor system through the relay device and received by the fluid delivery system include data indicative of the physiological characteristic level of the user.
76. The infusion system according to claim 75, wherein the communications including the data indicative of the physiological characteristic level of the user are automatically transmitted from the sensor system through the relay device and received by the fluid delivery system.
77. The infusion system according to claim 76, wherein the fluid delivery system further includes a display device contained in the delivery system housing and coupled to the delivery system processor for automatically displaying to the user the data indicative of the physiological characteristic level of the user.
78. The infusion system according to claim 76, wherein the fluid delivery system further includes:
a display device contained in the delivery system housing and coupled to the delivery system processor for displaying data to the user; and
a user interface contained in the delivery system housing and coupled to the delivery system processor for accepting one or more inputs from the user, wherein at least one of the inputs causes the display device to display the data indicative of the physiological characteristic level of the user received by the fluid delivery system.
79. The infusion system according to claim 76, wherein the fluid delivery system further includes a memory contained in the delivery system housing for storing the data indicative of the physiological characteristic level of the user received by the fluid delivery system.
80. The infusion system according to claim 79, wherein the fluid delivery system further includes a display device contained in the delivery system housing and coupled to the delivery system processor for displaying to the user a historical trend or graph using the stored data indicative of the physiological characteristic level of the user received by the fluid delivery system.
81. The infusion system according to claim 79, wherein the fluid delivery system further includes:
a display device contained in the delivery system housing and coupled to the delivery system processor for displaying data to the user; and
a user interface contained in the delivery system housing and coupled to the delivery system processor for accepting one or more inputs from the user, wherein at least one of the inputs causes the display device to display the most recent data indicative of the physiological characteristic level of the user received by the fluid delivery system.
82. The infusion system according to claim 75, wherein the fluid delivery system further includes:
a display device contained in the delivery system housing and coupled to the delivery system processor for displaying data to the user; and
a user interface contained in the delivery system housing and coupled to the delivery system processor for accepting one or more inputs from the user, wherein at least one of the inputs causes the display device to display the data indicative of the physiological characteristic level of the user received by the fluid delivery system.
83. The infusion system according to claim 75, wherein the fluid delivery system further includes a user interface contained in the delivery system housing and coupled to the delivery system processor for accepting one or more inputs from the user, wherein at least one of the inputs programs the amount of the fluid infused into the user based upon the data indicative of the physiological characteristic level of the user received by the fluid delivery system.
84. The infusion system according to claim 75, wherein the fluid delivery system further includes:
a bolus estimator used in conjunction with the delivery system processor for estimating the amount of the fluid to be infused into the user based upon the data indicative of the physiological characteristic level of the user received by the fluid delivery system;
an indication device coupled to the bolus estimator for indicating the estimated amount of fluid to be infused into the user; and
a user interface for accepting one or more inputs from the user, wherein at least one of the inputs accepts or modifies the estimated amount of the fluid to be infused into the user.
85. The infusion system according to claim 75, wherein the fluid delivery system further includes a closed loop algorithm executed by the delivery system processor for automatically determining the amount of the fluid to be infused into the user based upon the data indicative of the physiological characteristic level of the user received by the fluid delivery system and causing the fluid delivery system to infuse the determined amount of the fluid into the user.
86. The infusion system according to claim 75, wherein the fluid delivery system further includes an indication device for indicating when the data indicative of the physiological characteristic level of the user received by the fluid delivery system is above or below a target characteristic value.
87. The infusion system according to claim 75, wherein the data indicative of the physiological characteristic level of the user received by the fluid delivery system is uncalibrated data, and the fluid delivery system further includes a calibration algorithm executed by the delivery system processor for calibrating the uncalibrated data to generate one or more measurements indicative of the physiological characteristic level of the user.
88. The infusion system according to claim 74, wherein the sensor system format and the delivery system format utilize different frequencies for communications transmitted from the sensor system through the relay device and received by the fluid delivery system.
89. The infusion system according to claim 74, wherein the sensor system format and the delivery system format utilize different communication protocols for communications transmitted from the sensor system through the relay device and received by the fluid delivery system.
90. The infusion system according to claim 89, wherein the different communication protocols utilize different carrier media for communications transmitted from the sensor system through the relay device and received by the fluid delivery system.
91. The infusion system according to claim 89, wherein the different communication protocols utilize different information packaging for communications transmitted from the sensor system through the relay device and received by the fluid delivery system.
92. The infusion system according to claim 74, wherein the communications transmitted from the sensor system through the relay device and received by the fluid delivery system are transmitted using radio frequency communication.
93. The infusion system according to claim 74, wherein the communications transmitted from the sensor system through the relay device and received by the fluid delivery system are transmitted using infrared communication.
94. The infusion system according to claim 74, wherein the delivery system processor has a unique identification code, and the sensor system processor has the capability to learn the unique identification code of the delivery system processor, and further wherein the communications transmitted from the sensor system through the relay device and received by the fluid delivery system include the unique identification code of the delivery system processor to substantially avoid interference with other devices.
95. The infusion system according to claim 74, wherein the sensor system processor has a unique identification code, and the delivery system processor has the capability to learn the unique identification code of the sensor system processor, and further wherein the communications transmitted from the sensor system through the relay device and received by the fluid delivery system include the unique identification code of the sensor system processor to substantially avoid interference with other devices.
96. The infusion system according to claim 74, wherein the sensor system is a glucose monitoring system, and the fluid delivery system is an insulin infusion device.
Description
    RELATED APPLICATIONS
  • [0001]
    This application claims priority on U.S. Provisional Patent Application filed Dec. 19, 2002 and entitled “Relay Device for Transferring Information Between a Sensor System and a Fluid Delivery System,” which is herein specifically incorporated by reference.
  • BACKGROUND OF THE INVENTION
  • [0002]
    Ambulatory pumps and hospital-based fluid delivery systems are used to deliver fluids into the bodies of patients. For some therapies, sensor measurements of a patient's physiological characteristics are used to calculate fluid dosage requirements. Typically, a sensor monitor is used to collect sensor data from a sensor, calibrate the sensor data to generate sensor measurements, and display the sensor measurements. Next, the patient or a caregiver manually calculates the required fluid dosage based on the displayed sensor measurements. Finally, the patient or caregiver programs the pump or fluid delivery system to adjust the fluid dosage.
  • [0003]
    For example, patients with Type 1 diabetes and some patients with Type 2 diabetes use insulin to control their blood glucose (BG) level. Typically, if a patient's BG level is too high, the patient can inject a “bolus” (dose) of insulin to lower his/her BG level from its present level to a desired target level. Furthermore, the patient may inject a bolus of insulin in anticipation of ingesting carbohydrates, thus heading off a sharp rise in his/her BG level. Presently, a patient or caregiver must measure the patient's blood glucose using a BG monitoring system, such as a continuous glucose measurement system, a test strip meter, a hospital-based measurement system, or an automated intermittent blood glucose measurement system. When the BG monitoring system has generated a BG measurement, the BG measurement is displayed on the BG monitoring system. Next, the patient or caregiver must visually read and then utilize the BG measurement to manually calculate a required insulin bolus (i.e., the amount of insulin to inject). Finally, once the required insulin bolus is calculated, the patient or caregiver must utilize an insulin delivery device (e.g., infusion pump, injection pen, IV meter, or the like) to deliver the insulin bolus into the patient's body.
  • [0004]
    Unfortunately, this process requires the patient or caregiver to handle several pieces of equipment, including the BG monitoring system and the insulin delivery device, which may discourage the patient or caregiver from using the BG measurements to adjust the insulin dosage, and thus, decrease the efficacy of the insulin delivery device. Additionally, if the BG monitoring system and the insulin delivery device are not developed in conjunction with one another, they typically communicate using different frequencies and/or modes of communication, and as a result, cannot communicate directly with one another. Thus, the patient or caregiver must manually calculate the required insulin bolus and program the insulin delivery device accordingly, which requires effort by the patient or caregiver and is subject to calculation errors. Alternatively, the patient or caregiver must manually enter the BG measurement into an electronic computing device with bolus estimation software for calculating the required insulin bolus (e.g., a computer, the Internet, a personal digital assistant (PDA), or an insulin delivery device, such as an infusion pump, injection pen, IV meter, or the like), which also requires effort by the patient or caregiver and is subject to transcription errors. For example, the patient or caregiver may not accurately enter the BG measurement that is displayed on the BG measurement device into the electronic computing device, and thus, the resulting bolus estimate calculation may not be accurate.
  • SUMMARY OF THE INVENTION
  • [0005]
    It is an object of an embodiment of the present invention to provide an improved infusion system including a relay device for transferring information between a sensor system and a fluid delivery system, which obviates for practical purposes, the above mentioned limitations.
  • [0006]
    According to an embodiment of the invention, an infusion system for infusing a fluid into a user includes a sensor system, a relay device, and a delivery system. The sensor system includes a sensor system housing, a sensor coupled to the sensor system housing for producing a signal indicative of a physiological characteristic level of the user, a sensor system processor contained in the sensor system housing for processing the signal indicative of the physiological characteristic level of the user, and a sensor system transmitter contained in the sensor system housing and coupled to the sensor system processor for transmitting one or more communications in a sensor system format. The relay device includes a relay device receiver for receiving the communications from the sensor system in the sensor system format, a relay device processor for processing the communications from the sensor system and converting the communications for transmission in a delivery system format, and a relay device transmitter for transmitting the converted communications in the delivery system format. The fluid delivery system includes a delivery system housing, a delivery system receiver contained in the delivery system housing for receiving the communications from the relay device in the delivery system format, and a delivery system processor contained in the delivery system housing and coupled to the delivery system receiver for processing the communications from the relay device in the delivery system format and controlling an amount of the fluid infused into the user. Further, the amount of the fluid infused into the user is determined based upon data indicative of the physiological characteristic level of the user.
  • [0007]
    In particular embodiments, at least one of the communications transmitted from the sensor system through the relay device and received by the fluid delivery system include data indicative of the physiological characteristic level of the user. Additionally, the communications including the data indicative of the physiological characteristic level of the user may be automatically transmitted from the sensor system through the relay device and received by the fluid delivery system. Further, the fluid delivery system may also include a display device contained in the delivery system housing and coupled to the delivery system processor for automatically displaying to the user the data indicative of the physiological characteristic level of the user. Alternatively, the fluid delivery system may further include a display device contained in the delivery system housing and coupled to the delivery system processor for displaying data to the user, and a user interface contained in the housing and coupled to the delivery system processor for accepting one or more inputs from the user. At least one of the inputs may cause the display device to display the data indicative of the physiological characteristic level of the user received by the fluid delivery system. Also, the user interface may be dedicated for interfacing with the data indicative of the physiological characteristic level of the user received by the fluid delivery system.
  • [0008]
    In other particular embodiments, the fluid delivery system includes a memory contained in the delivery system housing for storing the data indicative of the physiological characteristic level of the user received by the fluid delivery system. Also, the fluid delivery system may include a display device contained in the housing and coupled to the delivery system processor for displaying to the user a historical trend or graph using the stored data indicative of the physiological characteristic level of the user received by the fluid delivery system.
  • [0009]
    In still other particular embodiments, the fluid delivery system may include a display device contained in the delivery system housing and coupled to the delivery system processor for displaying data to the user, and a user interface contained in the delivery system housing and coupled to the delivery system processor for accepting one or more inputs from the user. At least one of the inputs may cause the display device to display the most recent data indicative of the physiological characteristic level of the user received by the fluid delivery system. Also, at least a portion of the user interface may be dedicated for interfacing with the data indicative of the physiological characteristic level of the user received by the fluid delivery system.
  • [0010]
    In yet other particular embodiments, the fluid delivery system includes a display device contained in the delivery system housing and coupled to the delivery system processor for displaying data to the user, and a user interface contained in the delivery system housing and coupled to the delivery system processor for accepting one or more inputs from the user. At least one of the inputs causes the display device to display the data indicative of the physiological characteristic level of the user received by the fluid delivery system. Further, at least a portion of the user interface may be dedicated for interfacing with the data indicative of the physiological characteristic level of the user received by the fluid delivery system.
  • [0011]
    In still other embodiments, the fluid delivery system includes a user interface for accepting one or more inputs from the user, and the user interface is contained in the delivery system housing and coupled to the delivery system processor. At least one of the inputs programs the amount of the fluid infused into the user based upon the data indicative of the physiological characteristic level of the user received by the fluid delivery system. In yet other embodiments, the fluid delivery system includes a bolus estimator used in conjunction with the delivery system processor for estimating the amount of the fluid to be infused into the user based upon the data indicative of the physiological characteristic level of the user received by the fluid delivery system, an indication device coupled to the bolus estimator for indicating the estimated amount of fluid to be infused into the user, and a user interface for accepting one or more inputs from the user. At least one of the inputs accepts or modifies the estimated amount of the fluid to be infused into the user. In additional embodiments, the fluid delivery system includes a closed loop algorithm executed by the delivery system processor for automatically determining the amount of the fluid to be infused into the user based upon the data indicative of the physiological characteristic level of the user received by the fluid delivery system and causing the fluid delivery system to infuse the determined amount of the fluid into the user. In further embodiments, the fluid delivery system includes an indication device for indicating when the data indicative of the physiological characteristic level of the user received by the fluid delivery system is above or below a target characteristic value.
  • [0012]
    In still additional embodiments, the fluid delivery system includes a delivery system transmitter contained in the delivery system housing and coupled to the delivery system processor for transmitting one or more communications in the delivery system format. The relay device receiver further receives the communications from the fluid delivery system in the delivery system format, the relay device processor processes the communications from the fluid delivery system and converts the communications for transmission in the sensor system format, and the relay device transmitter transmits the converted communications in the sensor system format. Also, the sensor system further includes a sensor system receiver coupled to the sensor system processor for receiving the communications from the relay device in the sensor system format.
  • [0013]
    In still further embodiments, the fluid delivery system includes a display device contained in the delivery system housing and coupled to the delivery system processor for displaying data to the user, and a user interface contained in the delivery system housing and coupled to the delivery system processor for accepting one or more inputs from the user. At least one of the inputs generates a request for the data indicative of the physiological characteristic level of the user from the sensor system, at least one of the communications transmitted from the fluid delivery system through the relay device to the sensor system includes the request, and at least one of the communications including the data indicative of the physiological characteristic level of the user is transmitted from the sensor system through the relay device and received by the delivery system in response to the request. The display device then displays the data indicative of the physiological characteristic level of the user received by the fluid delivery system. Additionally, the user interface may be dedicated for interfacing from the fluid delivery system with the sensor system through the relay device. Also, the requested data is the most recent data indicative of the physiological characteristic level of the user received by the fluid delivery system.
  • [0014]
    In yet other embodiments, the data indicative of the physiological characteristic level of the user received by the fluid delivery system is uncalibrated data. The fluid delivery system includes a calibration algorithm executed by the delivery system processor for calibrating the uncalibrated data to generate one or more measurements indicative of the physiological characteristic level of the user.
  • [0015]
    In alternative embodiments, the data indicative of the physiological characteristic level of the user received by the fluid delivery system includes one or more calibrated measurements indicative of the physiological characteristic level of the user. In particular alternative embodiments, the sensor system includes a calibration algorithm executed by the sensor system processor for calibrating the signal indicative of the physiological characteristic level of the user to generate the one or more measurements indicative of the physiological characteristic level of the user, and the communications transmitted from the sensor system through the relay device and received by the fluid delivery system include the one or more measurements indicative of the physiological characteristic level of the user. In other particular alternative embodiments, the data indicative of the physiological characteristic level of the user received from the sensor system by the relay device is uncalibrated data. The relay device includes a calibration algorithm executed by the relay device processor for calibrating the uncalibrated data to generate one or more measurements indicative of the physiological characteristic level of the user, and the communications transmitted from the relay device and received by the fluid delivery system include the one or more measurements indicative of the physiological characteristic level of the user.
  • [0016]
    In additional alternative embodiments, at least one of the communications transmitted from the sensor system through the relay device and received by the delivery system includes one or more commands for programming the amount of the fluid infused into the user based upon the data indicative of the physiological characteristic level of the user. In some embodiments, the sensor system includes a display device coupled to the sensor system processor for displaying data to the user, and a user interface coupled to the sensor system processor for accepting one or more inputs from the user. At least one of the inputs causes the display device to display the data indicative of the physiological characteristic level of the user obtained by the sensor system. Also, at least another one of the inputs generates the one or more commands for programming the amount of the fluid infused into the user based upon the data indicative of the physiological characteristic level of the user obtained by the sensor system. In other embodiments, the sensor system includes a closed loop algorithm executed by the sensor system processor for automatically generating the one or more commands for programming the amount of the fluid to be infused into the user based upon the data indicative of the physiological characteristic level of the user obtained by the sensor system.
  • [0017]
    In further alternative embodiments, at least one of the communications transmitted from the sensor system to the relay device includes the data indicative of the physiological characteristic level of the user, and at least one of the communications transmitted from the relay device and received by the fluid delivery system includes one or more commands for programming the amount of the fluid infused into the user based upon the data indicative of the physiological characteristic level of the user. In particular embodiments, the relay device includes a display device coupled to the relay device processor for displaying data to the user, and a user interface coupled to the relay device processor for accepting one or more inputs from the user. At least one of the inputs causes the display device to display the data indicative of the physiological characteristic level of the user obtained by the sensor system. Also, at least another one of the inputs generates the one or more commands for programming the amount of the fluid infused into the user based upon the data indicative of the physiological characteristic level of the user obtained by the sensor system. In other particular embodiments, the relay device further includes a closed loop algorithm executed by the relay device processor for automatically generating the one or more commands for programming the amount of the fluid to be infused into the user based upon the data indicative of the physiological characteristic level of the user obtained by the sensor system.
  • [0018]
    In yet additional embodiments, the sensor system format and the delivery system format utilize different frequencies for communications transmitted from the sensor system through the relay device and received by the fluid delivery system. In some embodiments, the sensor system format and the delivery system format utilize different communication protocols for communications transmitted from the sensor system through the relay device and received by the fluid delivery system. The communication protocols may utilize different carrier media and/or information packaging for communications transmitted from the sensor system through the relay device and received by the fluid delivery system.
  • [0019]
    In particular embodiments, the delivery system processor has a unique identification code, and the sensor system processor has the capability to learn the unique identification code of the delivery system processor. Further, the communications transmitted from the sensor system through the relay device and received by the fluid delivery system include the unique identification code of the delivery system processor to substantially avoid interference with other devices. In other particular embodiments, the sensor system processor has a unique identification code, and the delivery system processor has the capability to learn the unique identification code of the sensor system processor. Further, the communications transmitted from the sensor system through the relay device and received by the fluid delivery system include the unique identification code of the sensor system processor to substantially avoid interference with other devices. In still other particular embodiments, the relay device processor has a unique identification code, and the sensor system processor has the capability to learn the unique identification code of the relay device processor. Also, the communications transmitted from the sensor system to the relay device include the unique identification code of the relay device processor to substantially avoid interference with other devices. In yet other particular embodiments, the relay device processor has a unique identification code, and the delivery system processor has the capability to learn the unique identification code of the relay device processor. Also, the communications transmitted from the relay device and received by the fluid delivery system include the unique identification code of the relay device processor to substantially avoid interference with other devices.
  • [0020]
    In additional embodiments, the relay device is coupled to the delivery system housing. In other embodiments, the relay device is contained in the delivery system housing. In still other embodiments, the relay device is coupled to the sensor system housing. In further embodiments, the sensor system is a glucose monitoring system, and the fluid delivery system is an insulin infusion device.
  • [0021]
    In another embodiment of the present invention, a relay device transfers information between a sensor system and a fluid delivery system. The sensor system measures a physiological characteristic level of a user, and the fluid delivery system infuses a fluid into the user. The relay device includes a sensor system receiver for receiving one or more communications from the sensor system in a sensor system format, a processor for processing the communications from the sensor system and converting the communications for transmission in a delivery system format, and a delivery system transmitter for transmitting the converted communications in the delivery system format to the fluid delivery system.
  • [0022]
    In some embodiments, the relay device includes a delivery system receiver for receiving one or more communications from the fluid delivery system in the delivery system format. The processor further processes the communications from the fluid delivery system and converts the communications for transmission in the sensor system format. The relay device also includes a sensor system transmitter for transmitting the converted communications in the sensor system format to the sensor system. In other embodiments, at least one of the communications transmitted from the sensor system through the relay device and received by the fluid delivery system include data indicative of the physiological characteristic level of the user. In yet other embodiments, at least one of the communications transmitted from the sensor system through the relay device and received by the fluid delivery system include one or more commands for programming an amount of the fluid to be infused into the user based upon data indicative of the physiological characteristic level of the user obtained by the sensor system.
  • [0023]
    In further embodiments, at least one of the communications transmitted from the sensor system to the relay device include data indicative of the physiological characteristic level of the user, and at least one of the communications transmitted from the relay device and received by the fluid delivery system include one or more commands for programming an amount of the fluid to be infused into the user based upon the data indicative of the physiological characteristic level of the user. Additionally, the relay device may include a display device coupled to the processor for displaying data to the user, and a user interface coupled to the processor for accepting one or more inputs from the user. At least one of the inputs causes the display device to display the data indicative of the physiological characteristic level of the user. Also, at least another one of the inputs generates the one or more commands for programming the amount of the fluid to be infused into the user based upon the data indicative of the physiological characteristic level of the user.
  • [0024]
    In still other embodiments, the sensor system format and the delivery system format utilize different frequencies for communications transmitted from the sensor system through the relay device to the fluid delivery system. In yet other embodiments, the sensor system format and the delivery system format utilize different communication protocols for communications transmitted from the sensor system through the relay device to the fluid delivery system. The communication protocols may utilize different carrier media and/or information packaging for communications transmitted from the sensor system through the relay device to the fluid delivery system.
  • [0025]
    In yet another embodiment of the present invention, a relay device transfers information between a sensor system and a fluid delivery system. The sensor system measures a physiological characteristic level of a user, and the fluid delivery system infuses a fluid into the user. The relay device includes a sensor system transceiver for transmitting and receiving one or more communications to and from the sensor system. The communications are transmitted and received in a sensor system format. The relay device also includes a delivery system transceiver for transmitting and receiving one or more communications to and from the fluid delivery system. The communications are transmitted and received in a delivery system format. The relay device further includes a processor for processing the communications from the sensor system and the fluid delivery system. The processor converts the communications received from the sensor system in the sensor system format for transmission in the delivery system format to the fluid delivery system, and further converts the communications received from the fluid delivery system in the delivery system format for transmission in the sensor system format to the sensor system.
  • [0026]
    In particular embodiments, at least one of the communications transmitted from the sensor system through the relay device and received by the fluid delivery system include data indicative of the physiological characteristic level of the user. In other particular embodiments, at least one of the communications transmitted from the sensor system through the relay device and received by the fluid delivery system include one or more commands for programming an amount of the fluid to be infused into the user based upon data indicative of the physiological characteristic level of the user obtained by the sensor system.
  • [0027]
    In additional embodiments, at least one of the communications transmitted from the sensor system to the relay device include data indicative of the physiological characteristic level of the user, and at least one of the communications transmitted from the relay device and received by the fluid delivery system include one or more commands for programming an amount of the fluid to be infused into the user based upon the data indicative of the physiological characteristic level of the user. Also, the relay device may include a display device coupled to the processor for displaying data to the user, and a user interface coupled to the processor for accepting one or more inputs from the user. At least one of the inputs causes the display device to display the data indicative of the physiological characteristic level of the user. Additionally, at least another one of the inputs generates the one or more commands for programming the amount of the fluid to be infused into the user based upon the data indicative of the physiological characteristic level of the user.
  • [0028]
    In further embodiments, the sensor system format and the delivery system format utilize different frequencies for communications transmitted between the sensor system and the fluid delivery system through the relay device. In additional embodiments, the sensor system format and the delivery system format utilize different communication protocols for communications transmitted between the sensor system and the fluid delivery system through the relay device. The communication protocols may utilize different carrier media and/or information packaging for communications transmitted between the sensor system and the fluid delivery system through the relay device.
  • [0029]
    In still another embodiment of the present invention, an infusion system for infusing a fluid into a user includes a sensor system and a fluid delivery system. The sensor system includes a sensor for producing a signal indicative of a physiological characteristic level of the user, a sensor system processor coupled to the sensor for processing the signal indicative of the physiological characteristic level of the user, and a sensor system transmitter coupled to the sensor system processor for transmitting one or more communications in a sensor system format. The fluid delivery system includes a delivery system housing, a relay device contained in the delivery system housing, a delivery system receiver, and a delivery system processor. The relay device includes a relay device receiver for receiving the communications from the sensor system in the sensor system format, a relay device processor for processing the communications from the sensor system and converting the communications for transmission in a delivery system format, and a relay device transmitter for transmitting the converted communications in the delivery system format. The delivery system receiver is contained in the delivery system housing and receives the communications from the relay device in the delivery system format. The delivery system processor is also contained in the delivery system housing and is coupled to the delivery system receiver, and processes the communications from the relay device in the delivery system format and controls an amount of the fluid infused into the user. The amount of the fluid infused into the user is determined based upon data indicative of the physiological characteristic level of the user obtained by the sensor system.
  • [0030]
    In particular embodiments, at least one of the communications transmitted from the sensor system through the relay device and received by the fluid delivery system include data indicative of the physiological characteristic level of the user. Additionally, the communications including the data indicative of the physiological characteristic level of the user may be automatically transmitted from the sensor system through the relay device and received by the fluid delivery system. Further, the fluid delivery system may also include a display device contained in the delivery system housing and coupled to the delivery system processor for automatically displaying to the user the data indicative of the physiological characteristic level of the user.
  • [0031]
    In other particular embodiments, the fluid delivery system includes a display device contained in the delivery system housing and coupled to the delivery system processor for displaying data to the user, and a user interface contained in the delivery system housing and coupled to the delivery system processor for accepting one or more inputs from the user. At least one of the inputs causes the display device to display the data indicative of the physiological characteristic level of the user received by the fluid delivery system.
  • [0032]
    In still other embodiments, the fluid delivery system includes a memory contained in the delivery system housing for storing the data indicative of the physiological characteristic level of the user received by the fluid delivery system. Additionally, the fluid delivery system may include a display device contained in the delivery system housing and coupled to the delivery system processor for displaying to the user a historical trend or graph using the stored data indicative of the physiological characteristic level of the user received by the fluid delivery system. Alternatively, the fluid delivery system may include a display device contained in the delivery system housing and coupled to the delivery system processor for displaying data to the user, and a user interface contained in the delivery system housing and coupled to the delivery system processor for accepting one or more inputs from the user. At least one of the inputs causes the display device to display the most recent data indicative of the physiological characteristic level of the user received by the fluid delivery system.
  • [0033]
    In additional embodiments, the fluid delivery system includes a display device contained in the delivery system housing and coupled to the delivery system processor for displaying data to the user, and a user interface contained in the delivery system housing and coupled to the delivery system processor for accepting one or more inputs from the user. At least one of the inputs causes the display device to display the data indicative of the physiological characteristic level of the user received by the fluid delivery system. In further embodiments, the fluid delivery system includes a user interface contained in the delivery system housing and coupled to the delivery system processor for accepting one or more inputs from the user. At least one of the inputs programs the amount of the fluid infused into the user based upon the data indicative of the physiological characteristic level of the user received by the fluid delivery system.
  • [0034]
    In yet other embodiments, the fluid delivery system includes a bolus estimator used in conjunction with the delivery system processor for estimating the amount of the fluid to be infused into the user based upon the data indicative of the physiological characteristic level of the user received by the fluid delivery system, an indication device coupled to the bolus estimator for indicating the estimated amount of fluid to be infused into the user, and a user interface for accepting one or more inputs from the user. At least one of the inputs accepts or modifies the estimated amount of the fluid to be infused into the user. In still further embodiments, the fluid delivery system includes a closed loop algorithm executed by the delivery system processor for automatically determining the amount of the fluid to be infused into the user based upon the data indicative of the physiological characteristic level of the user received by the fluid delivery system and causing the fluid delivery system to infuse the determined amount of the fluid into the user. In still additional embodiments, the fluid delivery system includes an indication device for indicating when the data indicative of the physiological characteristic level of the user received by the fluid delivery system is above or below a target characteristic value. In even additional embodiments, the data indicative of the physiological characteristic level of the user received by the fluid delivery system is uncalibrated data, and the fluid delivery system further includes a calibration algorithm executed by the delivery system processor for calibrating the uncalibrated data to generate one or more measurements indicative of the physiological characteristic level of the user.
  • [0035]
    In some embodiments, the sensor system format and the delivery system format utilize different frequencies for communications transmitted from the sensor system through the relay device and received by the fluid delivery system. In other embodiments, the sensor system format and the delivery system format utilize different communication protocols for communications transmitted from the sensor system through the relay device and received by the fluid delivery system. The different communication protocols may utilize different carrier media and/or information packaging for communications transmitted from the sensor system through the relay device and received by the fluid delivery system.
  • [0036]
    In yet further embodiments, the delivery system processor has a unique identification code, and the sensor system processor has the capability to learn the unique identification code of the delivery system processor. The communications transmitted from the sensor system through the relay device and received by the fluid delivery system include the unique identification code of the delivery system processor to substantially avoid interference with other devices. In yet additional embodiments, the sensor system processor has a unique identification code, and the delivery system processor has the capability to learn the unique identification code of the sensor system processor. The communications transmitted from the sensor system through the relay device and received by the fluid delivery system include the unique identification code of the sensor system processor to substantially avoid interference with other devices. Other features and advantages of the invention will become apparent from the following detailed description, taken in conjunction with the accompanying drawings which illustrate, by way of example, various features of embodiments of the invention.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • [0037]
    A detailed description of embodiments of the invention will be made with reference to the accompanying drawings, wherein like numerals designate corresponding parts in the several figures.
  • [0038]
    [0038]FIG. 1 is a block diagram of a system for transferring information between a blood glucose monitoring system and an infusion pump through a relay device in accordance with an embodiment of the present invention.
  • [0039]
    [0039]FIG. 2(a)-2(c) are perspective views of a blood glucose monitoring system in accordance with embodiments of the present invention.
  • [0040]
    [0040]FIG. 3(a) is a perspective view of an external infusion pump in accordance with an embodiment of the present invention.
  • [0041]
    [0041]FIG. 3(b) is a simplified block diagram of an external infusion pump in accordance with an embodiment of the present invention.
  • [0042]
    FIGS. 4(a)-5(f) are block diagrams of a system for transferring information between a blood glucose monitoring system and an infusion pump through a relay device in accordance with embodiments of the present invention.
  • [0043]
    FIGS. 6(a)-6(d) are perspective views of a relay device in accordance with embodiments of the present invention.
  • [0044]
    FIGS. 7(a)-7(c) are perspective views of a relay device placed on a body of a user in accordance with embodiments of the present invention.
  • [0045]
    FIGS. 8(a)-8(c) are perspective views of a relay device placed on an infusion pump in accordance with embodiments of the present invention.
  • [0046]
    [0046]FIG. 8(d) is a cut-away perspective view of an infusion pump with a relay device included in the infusion pump in accordance with another embodiment of the present invention.
  • [0047]
    FIGS. 9(a)-9(e) are block diagrams of a relay device in accordance with embodiments of the present invention.
  • [0048]
    [0048]FIG. 10 is a block diagram of a system for transferring information between a blood glucose monitoring system and an infusion pump using a relay device incorporated into the infusion pump in accordance with another embodiment of the present invention.
  • [0049]
    [0049]FIG. 11 is a block diagram of a system for transferring information between a blood glucose monitoring system and an infusion pump using a relay device incorporated into the infusion pump in accordance with yet another embodiment of the present invention.
  • [0050]
    [0050]FIG. 12 is a block diagram of a system for transferring information between a blood glucose monitoring system and an infusion pump using a relay device incorporated into the infusion pump in accordance with still another embodiment of the present invention.
  • DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
  • [0051]
    As shown in the drawings for purposes of illustration, the invention is embodied in a relay device for transferring information between a sensor system for measuring a physiological characteristic level of a user's body and a fluid delivery system for delivering fluid into the user's body. The relay device receives information from one system in a first format, converts the information into a second format appropriate for the other system, and then transmits the converted information to the other system. Therefore, the relay device enables communication between the sensor system and the fluid delivery system, even if the systems are not developed in conjunction with one another. For example, sensor data or measurements may be communicated from the sensor system via the relay device to the fluid delivery system, and then utilized to adjust the amount of fluid delivered by the fluid delivery system into the user's body. Thus, the relay device encourages the user or caregiver to utilize the sensor data or measurements in order to adjust the amount of fluid delivered into the user's body by the fluid delivery system. Further, the sensor measurements may be displayed on the fluid delivery system for the user or caregiver to see. Therefore, the relay device allows the user or caregiver to interface with the sensor system (e.g., view the sensor measurements) utilizing a single device, the fluid delivery system. Particular embodiments are directed toward use of ambulatory sensor and fluid delivery systems that are programmed and adjusted primarily by the user or a caregiver, such as the user's parent. Other embodiments are directed toward use of hospital-based sensor and fluid delivery systems that are programmed and adjusted primarily by a caregiver, such as the user's physician or nurse.
  • [0052]
    In preferred embodiments, the sensor system is a blood glucose (BG) monitoring system, which utilizes a sensor placed in a user to automatically measure the user's BG level, either periodically or continuously. In particular embodiments, the sensor may measure additional physiological characteristic levels of the user, such as blood oxygen, temperature, and the like. The sensor may be implanted in and/or through subcutaneous, dermal, sub-dermal, inter-peritoneal, or peritoneal tissue, and may be a sensor in contact with the user's body fluid, such as the user's blood, interstitial fluid, and the like. In preferred embodiments, the fluid delivery system is an insulin delivery device, such as an external insulin infusion pump, which regulates the amount of insulin delivered into the user's body. The relay device receives information from one system in a first format, converts the information into a second format appropriate for the other system, and then transmits the converted information to the other system. For example, the relay device may receive BG data or measurements from the BG monitoring system in a sensor system format (e.g., at a frequency of 131 kilohertz, utilizing radio frequency (RF) carrier media, in packets of 107 bytes), convert such data or measurements into a delivery system format appropriate for the insulin infusion pump (e.g., to a frequency of 916 megahertz, utilizing infrared (IR) carrier media, in packets of 71 bytes), and then transmit such converted data or measurements to the insulin infusion pump. The amount of insulin delivered into the user's body by the infusion pump may then be adjusted, either manually by the user or a caregiver or automatically, in response to the received BG data or measurements. In some embodiments, the BG measurements may also be displayed on the insulin infusion pump.
  • [0053]
    However, in alternative embodiments of the present invention, the sensor system may include other types of sensors, such as optical, enzymatic, fluorescent, or the like. In additional alternative embodiments, the sensor system may measure the user's BG level only when requested by the user, or a BG meter may be utilized to measure the user's BG level based on a sampling of the user's blood. In further alternative embodiments, the sensor system may measure other physiological characteristic levels of the user, such as heart rate, blood oxygen, pH, peroxide, respiratory rate, body temperature, blood pressure, perspiration, brain wave activity, cholesterol level, ketone level, medication concentration, viral load (e.g., HIV), and the like. The sensor system may also include multiple sensors—one or more sensors to measure the user's BG level and one or more sensors to measure such other physiological characteristic levels of the user. In other alternative embodiments, the sensor system may measure the physiological characteristic levels of the user from body fluids other than blood, such as interstitial fluid, spinal fluid, saliva, urine, tears, sweat, or the like. In still other alternative embodiments, the fluid delivery system may be an implantable infusion pump, an infusion pump that uses a combination of implantable and external components, a pen injector, a disposable pump, an intra venous drip system, or the like. In yet other alternative embodiments, the fluid delivery system may deliver fluids other than insulin, including peptides, proteins, sugars, vitamins, antigens, hormones, steroids, medicaments, drugs, pain killers, anti-cancer agents, anti-coagulants, stimulants, tranquilizers, sedatives, and the like. Particular embodiments are directed towards use in humans; however, alternative embodiments may be used in animals.
  • [0054]
    In preferred embodiments of the present invention, a relay device transfers information between a sensor system for measuring a physiological characteristic level of a user's body and a fluid delivery system for delivering fluid into the user's body. In the embodiment illustrated in FIG. 1, the sensor system is a BG monitoring system 20, which utilizes a sensor that is placed in a user to measure the user's BG level. The sensor may measure additional physiological characteristic levels of the user, such as blood oxygen, temperature, or the like.
  • [0055]
    In particular embodiments, the BG monitoring system 20 is an implantable glucose monitoring system, and is generally of the type described in U.S. Pat. No. 6,368,274, and disclosed in U.S. patent application Ser. No. 10/034,740, filed Dec. 27, 2001 and entitled “Implantable Sensor Flush Sleeve,” and U.S. Provisional Patent Application filed Sep. 27, 2002 and entitled “Implantable Sensor Method and System,” which are herein incorporated by reference. Referring to FIG. 2(a), the BG monitoring system 20 includes a glucose sensor set 50 and a glucose monitor 54. The sensor set 50 and glucose monitor 54 are implanted in the user's sub-dermal or inter-peritoneal tissue, and are in contact with the user's blood or other body fluid, to measure the user's BG level. For example, the sensor set 50 may be implanted into the central vein of the user's heart, and the glucose monitor 54 may be located in the user's chest cavity. Alternatively, the sensor set 50 may be placed in the user's peritoneum, and the glucose monitor 54 may be located in the user's abdominal cavity. The glucose monitor 54 includes a processor (not shown) for processing data as it is received from the sensor set 50, and a transmitter and/or receiver (not shown) for transferring the data to and/or from a data processor, such as a dedicated processor 56 designed specifically to work with the glucose monitor 54, a computer, communication station, or the like. The data processor 56 preferably comprises a relatively compact, portable housing that may be easily worn on clothing or jewelry, placed in a pocket, concealed under clothing, or the like. However, the BG monitoring system 20 may also be included in a hospital-based system, and the data processor 56 may comprise a housing that may be included in a monitor, placed on an intravenous (IV) pole, or the like near the patient's bed.
  • [0056]
    In other particular embodiments, the BG monitoring system 20 is a telemetered glucose monitoring system, and may generally be of the type described in U.S. patent application Ser. No. 09/377,472, filed Aug. 19, 1999 and entitled “Telemetered Characteristic Monitor System and Method of Using the Same,” which is herein incorporated by reference. The BG monitoring system 20 may also be a vascular glucose monitoring system, and may generally be of the type described in U.S. patent application Ser. No. 10/036,93, filed Dec. 28, 2001 and entitled “Sensing Apparatus and Process,” and U.S. Provisional Patent Application filed Sep. 27, 2002 and entitled “Multilumen Catheter,” which are herein incorporated by reference. Referring to FIG. 2(b), the BG monitoring system 20′ may include a glucose sensor set 50′ and a glucose monitor 54′. The sensor set 50′ includes a glucose sensor that is placed in and/or through the user's subcutaneous, dermal, sub-dermal, inter-peritoneal, peritoneal, muscle, lymph, or organ tissue, veins, arteries, or the like, and may be in contact with the user's blood or other body fluid, to measure the user's BG level. The sensor set 50′ is connected to the glucose monitor 54′ via a cable 52, and the glucose monitor 54′ includes a processor (not shown) for processing data as it is received from the sensor set 50′ via the cable 52. For example, the sensor set 50′ may be placed in the user's subcutaneous tissue, and the glucose monitor 54′ may be adhered to the user's body. Alternatively, the sensor set 50′ may be inserted into one lumen of a multilumen catheter, which may then be implanted in the central vein of the user's heart and include an extension lead for connecting to the glucose monitor 54′ via the cable 52, and the glucose monitor 54′ may be adhered to the user's body, as shown in FIG. 11. The other lumen(s) of the multilumen catheter may be utilized for sampling other physiological characteristic levels of the user and/or delivering fluids into the user's body, such as protein nutrition, blood products, medication, lipids, and the like. Such a multilumen catheter may generally be of the type described in U.S. Provisional Patent Application filed Sep. 27, 2002 and entitled “Multilumen Catheter,” which is herein incorporated by reference.
  • [0057]
    The glucose monitor 54′ may also include a transmitter and/or receiver (not shown) for transferring the data to and/or from a data processor, such as a dedicated processor 56′ designed specifically to work with the glucose monitor 54′ , a computer, communication station, or the like. The data processor 56′ preferably comprises a relatively compact, portable housing that may be easily worn on clothing or jewelry, placed in a pocket, concealed under clothing, or the like. However, the BG monitoring system 20 may also be included in a hospital-based system, and the data processor 56′ may comprise a housing that may be included in a monitor, placed on an intravenous (IV) pole, or the like near the patient's bed. In alternative embodiments, the cable 52 may be omitted, and the sensor set 50′ may be directly connected to the glucose monitor 54′.
  • [0058]
    In yet other particular embodiments, the BG monitoring system 20 may be a continuous glucose monitoring system, and may generally be of the type described in U.S. Pat. No. 6,424,847, which is herein incorporated by reference. Referring to FIG. 2(c), the BG monitoring system 20″ may include a glucose sensor set 50″ and a glucose monitor 5″. The sensor set 50″ includes a glucose sensor that is placed in and/or through the user's subcutaneous, dermal, sub-dermal, inter-peritoneal, peritoneal, muscle, lymph, or organ tissue, veins, arteries, or the like, and may be in contact with the user's blood or other body fluid, to measure the user's BG level. The sensor set 50″ is connected to the glucose monitor 54″ via a cable 52′, and the glucose monitor 54″ includes a processor (not shown) for processing data as it is received from the sensor set 50″ via the cable 52′. The glucose monitor 54″ comprises a relatively compact, portable housing that may be easily worn on clothing or jewelry, placed in a pocket, concealed under clothing, or the like. However, the BG monitoring system 20 may also be included in a hospital-based system, and the glucose monitor 54″ may comprise a housing that may be included in a monitor, placed on an intravenous (IV) pole, or the like near the patient's bed. The glucose monitor 54″ may also include a transmitter and/or receiver (not shown) for transferring the data to and/or from a data processor (not shown), such as a computer, communication station, or the like. In alternative embodiments, the cable 52′ may be omitted, and the sensor set 50″ may be directly connected to the glucose monitor 54″.
  • [0059]
    In alternative embodiments, the BG monitoring system 20 may include other types of sensors, such as optical, enzymatic, fluorescent, or the like. In further alternative embodiments, the sensor system may measure other physiological characteristic levels of the user, such as heart rate, blood oxygen, pH, peroxide, respiratory rate, body temperature, blood pressure, perspiration, brain wave activity, cholesterol level, ketone level, medication concentration, viral load (e.g., HIV), and the like. The sensor system may also include multiple sensors—one or more sensors to measure the user's BG level and one or more sensors to measure such other physiological characteristic levels of the user. For example, the BG monitoring system 20 may include a glucose sensor set 50 inserted in or on the user's body to measure the user's BG level and an oxygen sensor to measure the oxygen level at or near the insertion site of the sensor set 50. The measured oxygen level may then be used to determine the effectiveness of the sensor set 50, the formation of foreign bodies near the sensor set 50, or the like. In other alternative embodiments, the sensor system may measure the physiological characteristic levels of the user from body fluids other than blood, such as interstitial fluid, spinal fluid, saliva, urine, tears, sweat, or the like.
  • [0060]
    In particular embodiments, the BG monitoring system 20 automatically measures the user's BG level on a periodic basis. In other particular embodiments, the BG monitoring system 20 automatically measures the user's BG level on a continuous basis. In alternative embodiments, the BG monitoring system 20 may not automatically measure the user's BG level. For example, the BG monitoring system 20 may include a user interface, such as a keypad 60, which may be utilized by the user to request a BG measurement from the BG monitoring system 20. Alternatively, the BG monitoring system 20 may include a BG meter, which measures the user's BG level based on a sampling of the user's blood.
  • [0061]
    In preferred embodiments, the BG monitoring system 20 includes a transmitter and/or receiver (not shown) for communicating with external devices, such as a remote programmer (not shown) for the BG monitoring system 20, a BG meter (not shown), the relay device 10, the infusion pump 30 via the relay device 10, or the like. For example, the glucose monitor 54 and/or data processor 56 may include the transmitter and/or receiver. The BG monitoring system 20 preferably communicates with such external devices using radio frequency (RF) communication. Alternatively, other modes of communication may be utilized, such as infrared (IR), wired, ultrasonic, optical, or the like.
  • [0062]
    In particular embodiments, the BG monitoring system 20 may also include a display and a user interface. Referring to FIGS. 2(a)-2(b), the data processor 56 includes a display 58 and a keypad 60 with one or more keys. The glucose monitor 54 utilizes the transmitter and/or receiver (not shown) to transfer data to and/or from the data processor 56. Alternatively, referring to FIG. 2(c), the glucose monitor 54″ may include the display 58″ and keypad 60″ with one or more keys. The user may utilize the display 58 and/or keypad 60 to display the user's current BG level, view other BG information recorded or calculated by the glucose monitor 54 and/or data processor 56 (e.g., average BG level, BG trends, graphs of historical BG measurements), view alarms or other messages, program the BG monitoring system 20, enter calibration or other data into the BG monitoring system 20, download information from the BG monitoring system 20, and the like. In particular embodiments, the user may also utilize the display 58 and/or keypad 60 to transmit data, delivery commands, and/or other information to the infusion pump 30 via the relay device 10. In alternative embodiments, the user interface may include one or more buttons, switches, levers, joystick, roller ball, mouse, keyboard, and the like. In further alternative embodiments, the keypad 60 may be omitted, and the display 58 may be used as a touch screen input device. In other alternative embodiments, the display and/or user interface may be omitted from the BG monitoring system 20, and instead included on the relay device 10 and/or infusion pump 30.
  • [0063]
    In preferred embodiments, the BG monitoring system 20 stores information in a memory (not shown) of the BG monitoring system 20 for subsequent review and/or downloading to a storage media. Information stored by the BG monitoring system 20 may include one or more of raw BG data, calibrated BG measurements, time stamps, sensor alarms, sensor settings, calibration data, sensor performance data, sensor errors, sensor system diagnostics, statistics, user information, serial number, and the like. In preferred embodiments, information is transmitted from the BG monitoring system 20 to the infusion pump 30 via the relay device 10, and then downloaded to a storage media from the infusion pump 30. The storage media may include one or more of a personal computer (PC), a central server, an electronic memory, a personal digital assistant (PDA), a cell phone, a laptop computer, magnetic memory, silicon memory, a data storage device, and the like. In alternative embodiments, information may be downloaded to the storage media directly from the BG monitoring system 20 through an interface, such as a transmitter, a cable, a communication station, or the like. In particular alternative embodiments, information may be downloaded from the data processor 56 to the storage media. In other alternative embodiments, information may be downloaded from the glucose monitor 54 to the storage media. In further alternative embodiments, information may be transmitted from the BG monitoring system 20 to the relay device 10, and then downloaded to the storage media from the relay device 10. In other alternative embodiments, information may be downloaded to the storage media from more than one of the BG monitoring system 20, relay device 10, and infusion pump 30.
  • [0064]
    In preferred embodiments, sensor calibration data is provided to the BG monitoring system 20 by communication with an external device, such as a BG meter or other BG measuring device (not shown). The BG monitoring system 20 preferably includes a transmitter and/or receiver (not shown) for communicating with such external devices. For example, the glucose monitor 54 and/or the data processor 56 may include the transmitter and/or receiver. The user obtains a BG reference reading utilizing a BG meter or other BG measuring device, which then transmits the BG reference reading to the BG monitoring system 20, either directly or via the relay device 10. In alternative embodiments, the user may manually enter sensor calibration data into the BG monitoring system 20. In particular alternative embodiments, the user may utilize the display 58 and/or user interface 60 on the data processor 56, as shown in FIGS. 2(a)-2(b), to manually input the calibration data into the BG monitoring system 20. In other particular alternative embodiments, the user may utilize the display 58″ and/or user interface 60″ on the glucose monitor 54″ , as shown in FIG. 2(c), to manually input the calibration data into the BG monitoring system 20.
  • [0065]
    In the embodiment illustrated in FIGS. 1 and 3(a)-3(b), the fluid delivery system is an external infusion pump 30, which regulates the flow of fluid, preferably medication such as insulin, through flexible tubing 32 and into an infusion set 34 or the like that is adhered to the user's body. Infusion sets 34 that may be used are described in, but not limited to, U.S. Pat. Nos. 4,723,947; 4,755,173; 5,176,662; 5,584,813; and 6,056,718, which are herein incorporated by reference. The infusion pump 30 is generally of the type described in U.S. Pat. Nos. 4,562,751; 4,685,903; 5,080,653; 5,097,122; 5,505,709; and 6,248,093; and disclosed in U.S. patent application Ser. No. 09/334,858, filed Jun. 16, 1999 and entitled “External Infusion Device with Remote Programming, Bolus Estimator and/or Vibration Alarm Capabilities,” which are herein incorporated by reference. In alternative embodiments, the fluid delivery system may be an implantable infusion pump, an infusion pump that uses a combination of implantable and external components, a pen injector, disposable pump, an intra venous drip system, or the like. In still other alternative embodiments, the fluid delivery system may deliver fluids other than insulin, including peptides, proteins, sugars, vitamins, antigens, hormones, steroids, medicaments, drugs, pain killers, anti-cancer agents, anti-coagulants, stimulants, tranquilizers, sedatives, and the like.
  • [0066]
    Referring to FIGS. 3(a)-3(b), the infusion pump 30 comprises a relatively compact, portable housing that may be easily worn on clothing or jewelry, placed in a pocket, concealed under clothing, or the like. However, the infusion pump 30 may also be included in a hospital-based system, and the infusion pump 30 may comprise a housing that may be included in a monitor, placed on an intravenous (IV) pole, or the like near the patient's bed. The infusion pump 30 preferably includes a processor 150 for running programs and controlling the infusion pump 30. The processor 150 is coupled to an internal memory device 154 that stores programs, history data, user defined information and parameters. In preferred embodiments, the memory device 154 is a ROM and DRAM; however, in alternative embodiments, the memory device 154 may include other memory storage devices, such as RAM, EPROM, dynamic storage such as flash memory, energy efficient hard-drive, or the like. The processor 150 is also coupled to a drive mechanism 160 that is connected to a fluid reservoir 162 containing fluid that is delivered through the tubing 32 and into the infusion set 34 adhered to the user's body. The processor 150 may additionally be coupled to a bolus estimator 164, which estimates an appropriate amount of insulin to be delivered to the user based on the user's BG level, the amount of carbohydrates to be consumed, and the like. The bolus estimator 164 may generally be of the type described in U.S. patent application Ser. No. 09/334,858, filed Jun. 16, 1999 and entitled “External Infusion Device with Remote Programming, Bolus Estimator and/or Vibration Alarm Capabilities,” which is herein incorporated by reference.
  • [0067]
    The infusion pump 30 further includes a communication system 152 coupled to the processor 150 for communicating with external devices, such as a remote programmer (not shown) for the infusion pump 30, the BG monitoring system 20 via the relay device 10, the relay device 10, or the like. The communication system 152 may include a transmitter and/or receiver (not shown) for communicating with such external devices. The infusion pump 30 preferably communicates with such external devices using radio frequency (RF) communication. Alternatively, other modes of communication may be utilized, such as infrared (IR), wired, ultrasonic, optical, or the like.
  • [0068]
    In some embodiments, the transmitter and/or receiver (not shown) of the communication system 152 may be capable of communicating with certain external devices utilizing a particular frequency and/or communication protocol, such as the remote programmer (not shown) for the infusion pump 30 or the like. The infusion pump 30 may include another transmitter and/or receiver (not shown) as part of the relay device 10 incorporated in the infusion pump 30 itself (as shown and described below in the embodiment of FIGS. 8(d) and 10-12), which is capable of communicating with other external devices utilizing another particular frequency and/or communication protocol, such as the BG monitoring system 20 or the like. In other embodiments, the transmitter and/or receiver (not shown) of the communication system 152 may be capable of communicating with various external devices utilizing different frequencies and/or communication protocols.
  • [0069]
    The infusion pump 30 also includes a display 100 and/or a user interface 110. In preferred embodiments, the display 100 is a monochromatic liquid crystal display (LCD). In alternative embodiments, the display 100 is a light emitting diode (LED) display, a cathode ray tube (CRT) display, a touch screen, a color LCD, or the like.
  • [0070]
    In preferred embodiments, the user interface is a keypad 110 including one or more keys with selectable functions. The infusion pump 30 is preferably programmed through the keypad 110, or alternatively, by commands received from an external device, such as a remote programmer, the BG monitoring system 20 via the relay device 10, the relay device 10, or the like. The keypad 110 may generally be of the type, and operate in a manner similar to that, disclosed in U.S. patent applications Ser. No. 09/334,858, filed Jun. 16, 1999 and entitled “External Infusion Device with Remote Programming, Bolus Estimator and/or Vibration Alarm Capabilities,” and Ser. No. 09/784,949, filed Feb. 15, 2001 and entitled “Improved Infusion Device Menu Structure and Method of Using the Same,” which are herein incorporated by reference.
  • [0071]
    In the illustrated embodiment, the keypad 110 includes an Up-Arrow key 112, a Down-Arrow key 114, an ACT (activate) key 116, an ESC (escape) key 118, and an Express Bolus key 120 for programming the infusion pump 30. The keypad 110 also includes a dedicated key 122 for interfacing with the BG monitoring system 20 via the relay device 10. In particular embodiments, the user chooses a function and then selects which key will perform that function. For example, while the display 100 is blank, the user may select the Express Bolus key 120 to quickly set a bolus amount, or the ESC key 118 to show a status information screen on the display 100. In other particular embodiments, the user selects one or more keystrokes to perform a function. For example, while the display 100 is blank, the user may first select the ACT key 116 to show a main menu screen, then the Up-Arrow and Down-Arrow keys 112 and 114 to scroll through the menu choices, and then the ACT key 116 again to select a menu option. The user selects the keys 112, 114, 116, 118, 120, and/or 122 on the keypad 110 to perform functions on the infusion pump 30, such as starting or stopping a bolus or basal delivery, accessing historical data or status information, setting a utility (e.g., date, time, serial number, or the like), turning on or off a feature (e.g., light, key lock, temporary operation, or the like), escaping to a home display screen, backing up to a previous screen, deleting or approving an input, scrolling, priming, resetting, and the like. In particular embodiments, the display 100 and/or user interface 110 may also be utilized to input information into and/or display information from the BG monitoring system 20 via the relay device 10, such as viewing sensor measurements received from the BG monitoring system 20 on the display 100 of the infusion pump 30. In alternative embodiments, the keypad 110 may include more or less keys, or have different key arrangements than those illustrated in the figures.
  • [0072]
    In further alternative embodiments, one or more keys on the keypad 110 may be programmable. In particular embodiments, the user may define one or more keystrokes to cause the infusion pump 30 to perform one or more functions. For example, a first user may define key 120 on a first infusion pump 30 to cause the display 100 to show the most recent sensor measurement, while a second user may define key 120 on a second infusion pump 30 to perform an express bolus function. In other alternative embodiments, the user interface may include one or more buttons, switches, levers, joysticks, roller balls, mice, keyboards, and the like. In still other alternative embodiments, the keypad 110 may be omitted, and the display 100 may be used as a touch screen input device.
  • [0073]
    The infusion pump 30 may provide feedback to the user on status or programming changes visibly on the display 100 and/or through lights (not shown) on the infusion pump 30, audibly through a speaker 156, and/or tactilely through a vibrator 158. The infusion pump 30 may also provide the user with a visible alarm via the display 100 and/or lights, an audible alarm via the speaker 156, and/or a vibration alarm via the vibrator 158, such as a warning that is indicative of a low reservoir or low battery, an alarm or warning that is indicative of a sensor measurement received from the BG monitoring system 20 via the relay device 10 that is above or below target glycemic values, or the like. In alternative embodiments, the display 100, keypad 110, lights, speaker 156, and/or vibrator 158 may be omitted from the infusion pump 30, and instead, included on the relay device 10 and/or the BG monitoring system 20. In further alternative embodiments, the display 100, keypad 110, lights, speaker 156, and/or vibrator 158 may be omitted, the infusion pump 30 may be implanted in the user's body, and all programming may be handled through a communication system using wireless modes of communication, such as radio frequency (RF), infrared (IR), and the like.
  • [0074]
    In preferred embodiments, the infusion pump 30 stores information in a memory (not shown) of the infusion pump 30 for subsequent review and/or downloading to a storage media. Information stored by the infusion pump 30 includes one or more of insulin delivery rates, insulin bolus amounts, time stamps, alarms, errors, warnings, utility settings, statistics, profiles, user information, serial number, commands, force measurements, pressure measurements, and the like. In preferred embodiments, information is downloaded directly from the infusion pump 30 to a storage media through an interface, such as a transmitter, cable, communication station, or the like. In particular embodiments, an external communication link (not shown) may be connected via a cable to a serial, USB, or the like port of a computer. The infusion pump 30 may include an RF transmitter or transceiver (not shown), which transmits information to an RF receiver or transceiver in the external communication link for downloading to the computer. In other particular embodiments, information may be downloaded from the infusion pump 30 through a communication station generally of the type disclosed in U.S. Pat. No. 5,376,070, which is herein incorporated by reference. In still other particular embodiments, information may be downloaded from the infusion pump 30 through a BG meter (not shown) as disclosed in U.S. Provisional Patent Application Serial No. 60/412,998, filed Sep. 23, 2002 and entitled “System for Providing Blood Glucose Measurements to Bolus Estimator,” which is herein incorporated by reference. The storage media may include one or more of a personal computer (PC), a central server, an electronic memory, a personal digital assistant (PDA), a cell phone, a laptop computer, magnetic memory, silicon memory, a data storage device, and the like. In alternative embodiments, information may be transmitted from the infusion pump 30 to the BG monitoring system 20 via the relay device 10, and then downloaded to a storage media from the BG monitoring system 20. In further alternative embodiments, information may be transmitted from the infusion pump 30 to the relay device 10, and then downloaded to the storage media from the relay device 10. In other alternative embodiments, information may be downloaded to the storage media from more than one of the BG monitoring system 20, relay device 10, and infusion pump 30.
  • [0075]
    In the embodiment illustrated in FIG. 1, the relay device 10 transfers information between the BG monitoring system 20 and the infusion pump 30. In preferred embodiments, the relay device 10 comprises a relatively compact, portable housing 200 without a user interface or a display, as illustrated in FIG. 6(a). The relay device 10 may be easily worn on clothing or jewelry, placed in a pocket, concealed under clothing, or the like. In alternative embodiments, the relay device 10′ may include a housing 200′ with a single key 202, as shown in FIG. 6(b). The single key 202 provides a user interface for the user to request new information from the BG monitoring system 20.
  • [0076]
    In further alternative embodiments, the relay device 10″ may include a housing 200″ with a keypad 204, as shown in FIG. 6(c). The keypad 204 may include more than one key, and at least one of the keys may be utilized by the user to send data or commands to the infusion pump 30. In the illustrated embodiment, the keypad 204 includes an Up-Arrow key 206, a Down-Arrow key 208, and an ACT (activate) key 210 for programming the infusion pump 30 from the relay device 10 in a manner similar to that shown and described in the embodiment of FIG. 3(a). The keypad 204 also includes a dedicated key 212 for interfacing with and requesting data from the BG monitoring system 20. However, in alternative embodiments, the keypad 204 may include more or less keys or different key arrangements than those illustrated in FIG. 6(c).
  • [0077]
    In other alternative embodiments, the relay device 10′″ may include a housing 200′″ with a display 214 and a keypad 216, as shown in FIG. 6(d). In particular alternative embodiments, the display 214 may be a monochromatic liquid crystal display (LCD). In other particular alternative embodiments, the display 214 may be a light emitting diode (LED) display, a cathode ray tube (CRT) display, a touch screen, a color LCD, or the like. The keypad 216 may include more than one key, and at least one of the keys may be utilized by the user to send data or commands to the infusion pump 30. In the illustrated embodiment, the keypad 216 includes an Up-Arrow key 218, a Down-Arrow key 220, an ACT (activate) key 222, and an ESC (escape) key 224 for programming the infusion pump 30 from the relay device 10 in a manner similar to that shown and described in the embodiment of FIG. 3(a). The keypad 216 also includes a dedicated key 226 for interfacing with and requesting data from the BG monitoring system 20. However, in alternative embodiments, the keypad 216 may include more or less keys or different key arrangements than those illustrated in FIG. 6(d). In still other alternative embodiments, the relay device 10 may be a computer system (not shown), such as a personal computer (PC), a personal digital assistant (PDA), a central data system (such as is used in hospitals to store or track data, Internet systems, or the like), or the like.
  • [0078]
    In preferred embodiments, the relay device 10 is positioned on the user's body near the BG monitoring system 20. For example, the relay device 10 may be positioned on the user's is body using a necklace 250 to hold the relay device 10 like a pendant (as shown in FIG. 7(a)), using a belt or strap 252 to hold the relay device 10 in place (as shown in FIG. 7(b)), or by placing the relay device 10 in a clothing garment 254 or clipping the relay device 10 in place (as shown in FIG. 7(c)). Positioning the relay device 10 near the BG monitoring system 20 is especially useful to minimize the power required by the transmitter and/or receiver in the BG monitoring system 20 to send and/or receive signals between the BG monitoring system 20 and the relay device 10. Other methods may be used to locate the relay device 10 near the BG monitoring system 20, such as using tape or adhesive to hold the relay device 10 in place, holding the relay device 10 in a hand and bringing the hand near the BG monitoring system 20, or the like.
  • [0079]
    In alternative embodiments, the relay device 10 may be incorporated with the infusion pump 30 to minimize the number of components that the user must handle. For example, the relay device 10 may be incorporated into a clip that is attached to the infusion pump 30 to hold the infusion pump 30 in place on the user's body, as shown in FIG. 8(a). Alternatively, the relay device 10′ may be mounted on a side of the infusion pump 30, as shown in FIG. 8(b). Additionally, the relay device 10″ may be attached to a bottom of the infusion pump 30, as shown in FIG. 8(c). In other alternative embodiments, the relay device 10 may be incorporated with the BG monitoring system 20 in a manner similar to that shown and described in the embodiments of FIGS. 8(a)-8(c). For example, the relay device 10 may be incorporated into a clip that is attached to, or mounted on a side of, or attached to a bottom of, the data processor 56 shown in FIGS. 2(a)-2(b) or the glucose monitor 54″ shown in FIG. 2(c).
  • [0080]
    In further alternative embodiments, the relay device 10 may be incorporated into the infusion pump 30. FIG. 8(d) illustrates a cut-away perspective view of the infusion pump 30 showing the electronic boards and modules that may be included in the infusion pump 30. The infusion pump 30 may include a display module 260, a mother board 262, and an interface board 264. The mother board 262 is the main control unit for the infusion pump 30, and includes the processor and memory. The display module 260 includes the display 100, and in particular embodiments, a backlight for the display 100. The interface board 264 interfaces between different systems in the infusion pump 30, and includes the drive mechanism and power supplies. The infusion pump 30 also includes a communication board 265 and an antenna 268, which enable communication with external devices, such as a remote programmer (not shown) for the infusion pump 30, the BG monitoring system 20, and the like. The communication board 265 includes the communication system as well as the relay device components. During communications with the BG monitoring system 20, the drive mechanism and power supplies on the interface board 264 are temporarily shutdown. Accordingly, the infusion pump 30 further includes a capacitor 266 for providing power to the infusion pump 30 and the communication board 265 during such communications.
  • [0081]
    For example, referring to FIGS. 10-12, the relay device (not shown) may be incorporated into the infusion pump 30. The BG monitoring system 20 may transmit communications to the infusion pump 30 in a sensor system format, the relay device incorporated into the infusion pump 30 may receive such communications and convert them to a delivery system format, and the infusion pump 30 may then process such converted communications. Conversely, the infusion pump 30 may format communications in the delivery system format, the relay device incorporated into the infusion pump 30 may convert such communications to the sensor system format and transmit such converted communications, and the BG monitoring system 20 may receive such communications in the sensor system format. In particular embodiments, the BG monitoring system 20 may communicate with the infusion pump 30 using wireless modes of communication, such as radio frequency (RF), infrared (IR), ultrasonic, sonic, optical, and the like, as shown in FIGS. 10 and 11. In other particular embodiments, the BG monitoring system 20 may communicate with the infusion pump 30 using a wired connection 35, as shown in FIG. 12.
  • [0082]
    In particular embodiments, information may be downloaded directly from the relay device 10 to a storage media through an interface, such as a transmitter, a cable, a communication station, or the like. For example, information stored by the BG monitoring system 20 and/or the infusion pump 30 may be transmitted to the relay device 10, and then downloaded from the relay device 10 to the storage media. The storage media may include one or more of a personal computer (PC), a central server, an electronic memory, a personal digital assistant (PDA), a cell phone, a laptop computer, magnetic memory, silicon memory, a data storage device, and the like. In alternative embodiments, information may be downloaded directly from the BG monitoring system 20 or the infusion pump 30 to a storage media. In further alternative embodiments, information may be downloaded to the storage media from more than one of the BG monitoring system 20, relay device 10, and infusion pump 30.
  • [0083]
    In preferred embodiments, the relay device 10 communicates with the BG monitoring system 20 and the infusion pump 30 using radio frequency (RF) communication. In alternative embodiments, other modes of communication may be used, such as infrared (IR), wired, ultrasonic, sonic, optical, and the like. In further alternative embodiments, more than one mode of communication may be utilized by the relay device 10.
  • [0084]
    In preferred embodiments, the relay device 10 includes an RF mixer 300, a first microcontroller 302, a second microcontroller 304, and an RF transceiver 306, as shown in FIG. 9(a). The RF mixer 300 receives an RF signal from the BG monitoring system 20 and forwards the signal to the first microcontroller 302. The first microcontroller 302 decodes the RF signal received in a first format from the BG monitoring system 20 (e.g., at a frequency of 131 kilohertz), and forwards the decoded signal to the second microcontroller 304. Next, the second microcontroller 304 processes and encodes the signal into a second format for the infusion pump 30 (e.g., at a frequency of 916 megahertz), and forwards the encoded signal to the RF transceiver 306. The RF transceiver 306 then transmits the encoded signal to the infusion pump 30. Conversely, the RF transceiver 306 receives an RF signal from the infusion pump 30 and forwards the signal to the second microcontroller 304. The second microcontroller 304 decodes the RF signal received in the second format from the infusion pump 30, and forwards the decoded signal to the first microcontroller 302. Next, the first microcontroller 302 processes and encodes the signal into the first format for the BG monitoring system 20, and forwards the encoded signal to the RF mixer 300. The RF mixer 300 then transmits the encoded signal to the BG monitoring system 20. Inclusion of the two microcontrollers 302 and 304 allows the relay device 10 to encode and decode signals for the BG monitoring system 20 and the infusion pump 30 simultaneously.
  • [0085]
    In alternative embodiments, the two microcontrollers 302 and 304 shown in FIG. 9(a) may be replaced with a single fast microcontroller 308, as illustrated in FIG. 9(b). The fast microcontroller 308 encodes and decodes signals in appropriate formats respectively for the BG monitoring system 20 and the infusion pump 30 in a manner similar to that of the two microcontrollers 302 and 304 shown in FIG. 9(a). In further alternative embodiments, the relay device 10″ may include an RF mixer 320 and an RF transceiver 326, as illustrated in FIG. 9(c), which are similar to the RF mixer 300 and RF transceiver 306 shown in FIGS. 9(a) and 9(b). The relay device 10″ may also include a field programmable gate array (FPGA) 322, which performs functions similar to the first microcontroller 302 shown in FIG. 9(a), for encoding and decoding signals in an appropriate format for the BG monitoring system 20. The relay device 10″ may further include a microcontroller 322, which is similar to the second microcontroller 304 shown in FIG. 9(a), for encoding and decoding signals in an appropriate format for the infusion pump 30.
  • [0086]
    In other alternative embodiments, the relay device 10′″ may include an application specific integrated circuit (ASIC) 340, which incorporates an RF mixer for transmitting and receiving signals to and from the BG monitoring system 20, as illustrated in FIG. 9(d). The ASIC 340 may also encode and decode information in an appropriate format for the BG monitoring system 20. Additionally, the relay device 10′″ may include a microcontroller 342, which is similar to the second microcontroller 304 shown in FIG. 9(a), for encoding and decoding signals in an appropriate format for the infusion pump 30. The relay device 10′″ may further include an RF transceiver 344, which is similar to the RF transceiver 306 shown in FIG. 9(a), for transmitting and receiving signals to and from the infusion pump 30. In still other alternative embodiments, the microcontroller 342 shown in FIG. 9(d) may be omitted, and the functionality instead may be included in an application specific integrated circuit (ASIC_360, as shown in FIG. 9(e). The ASIC 360 transmits and receives signals to and from the BG monitoring system 20. The ASIC 360 also encodes and decodes signals in appropriate formats respectively for the BG monitoring system 20 and infusion pump 30. The relay device 10″″ may further include an RF transceiver 362, which is similar to the RF transceiver 306 shown in FIG. 9(a), for transmitting and receiving signals to and from the infusion pump 30.
  • [0087]
    Referring to FIG. 1, the relay device 10 receives information from the BG monitoring system 20 in a sensor system format, converts the information into a delivery system format appropriate for the infusion pump 30, and then transmits the converted information in the delivery system format to the infusion pump 30. The relay device 10 may also receive information from the infusion pump 30 in the delivery system format, convert the information into the sensor system format appropriate for the BG monitoring system 20, and then transmit the converted information in the sensor system format to the BG monitoring system 20. In alternative embodiments, communication is in only one direction, either from the BG monitoring system 20 to the infusion pump 30, or from the infusion pump 30 to the BG monitoring system 20.
  • [0088]
    In preferred embodiments, the sensor system and delivery system formats include one or more frequencies, communication protocols, and the like that are used to transfer information between the BG monitoring system 20 and the infusion pump 30. For example, the sensor system format utilized by the BG monitoring system 20 may include a lower frequency, such as 131 kilohertz, resulting in less tissue attenuation at and/or near the insertion site of the BG monitoring sensor set 50. The delivery system format utilized by the infusion pump 30 may include a higher frequency, such as 916 megahertz or 402-405 megahertz, ensuring compliance with federal, state, regulatory, and other requirements for RF communications. However, other frequencies may be utilized by the BG monitoring system 20 and/or infusion pump 30.
  • [0089]
    The communication protocols specify carrier media for communication, such as radio frequency (RF) (including frequency modulated (FM), amplitude modulated (AM), and the like RF), infrared (IR), ultrasonic, audio, light wave, Bluetooth, IRDA, conductive using wires or other direct contacts, and the like. The communication protocols also specify information packaging, which includes how the information is arranged and sent on the carrier media. For example, the information packaging may specify which data components are sent (e.g., the serial number of the relay device 10, BG monitoring system 20, and/or infusion pump 30, a date and time stamp, a sensor measurement, a pump command, and the like). The information packaging may also specify the order in which data components are sent. Further, the information packaging may specify how the information is sent, such as in packets, bits, words, and the like. The information packaging may additionally specify how the information is expressed, such as in decimal, hexadecimal, DC balanced format, and the like.
  • [0090]
    The BG monitoring system 20 utilizes a sensor system communication protocol, and the infusion pump 30 utilizes a delivery system communication protocol. For example, the BG monitoring system 20 uses the sensor system communication protocol to communicate with the relay device 10, and the infusion pump 30 uses the delivery system communication protocol to communicate with the relay device 10. In particular embodiments, the BG monitoring system 20 and infusion pump 30 do not use the same communication protocol; thus, the relay device 10 converts information received from the BG monitoring system 20 into the delivery system communication protocol for communicating to the infusion pump 30, and the relay device 10 converts information received from the infusion pump 30 into the sensor system communication protocol for communicating to the BG monitoring system 20. For example, the relay device 10 may receive BG data or measurements from the BG monitoring system 20 formatted in the sensor system communication protocol utilizing radio frequency carrier media, in packets of 107 bytes, or the like. The relay device 10 converts such data or measurements into the delivery system communication protocol utilizing infrared carrier media, in packets of 71 bytes, or the like, and then transmits such converted data or measurements formatted in the delivery system communication protocol to the infusion pump 30. However, other carrier media or information packaging may be utilized by the BG monitoring system 20 and/or infusion pump 30.7 In preferred embodiments, the relay device 10, BG monitoring system 20, infusion pump 30, and other devices capable of communicating with the relay device 10, BG monitoring system 20, and/or infusion pump 30 (e.g., remote programmer for the BG monitoring system 20, remote programmer for the infusion pump 30, and the like) each have a unique identification (ID) code, such as a serial number, identification number, password, or the like. The ID code may be included in communications transmitted to and received from the relay device 10, BG monitoring system 20, and/or infusion pump 30 in order to ensure security and/or to distinguish information from various sources. In particular embodiments, each packet of information that is transmitted to the relay device 10 may include the ID code for the relay device 10, and the relay device 10 may use the ID code to discern whether the packet of information is intended for the relay device 10. Similarly, each packet of information that is transmitted to the BG monitoring system 20 may include the ID code for the BG monitoring system 20, and the BG monitoring system 20 may use the ID code to discern whether the packet of information is intended for the BG monitoring system 20. Also, each packet of information that is transmitted to the infusion pump 30 may include the ID code for the infusion pump 30, and the infusion pump 30 may use the ID code to discern whether the packet of information is intended for the infusion pump 30. In further particular embodiments, the relay device 10, BG monitoring system 20, infusion pump 30, and other devices capable of communicating with the relay device 10, BG monitoring system 20, and/or infusion pump 30 may know each other's unique ID code. The BG monitoring system 20 and/or the infusion pump 30 may respond to commands and accept information only from devices for which they know such ID codes. For example, the BG monitoring system 20 may communicate with the infusion pump 30 through the relay device 10, and thus, may know the ID codes for the relay device 10 and infusion pump 30. Conversely, the infusion pump 30 may communicate with the BG monitoring system 20 through the relay device 10, and thus, may know the ID codes for the relay device 10 and BG monitoring system 20. The infusion pump 30 may also know the ID code for a remote programmer. In alternative embodiments, the relay device 10, BG monitoring system 20, infusion pump 30, and other devices capable of communicating with the BG monitoring system 20 and/or infusion pump 30 have no ID code.
  • [0091]
    In preferred embodiments, the BG monitoring system 20 is continually synchronized with any device that communicates with the BG monitoring system 20, such as the relay device 10, the infusion pump 30 via the relay device 10, and the like. The BG monitoring system 20 transmits information at fixed intervals (e.g., once every thirty seconds, minute, five minutes, ten minutes, twenty minutes, or the like) for exact time periods (e.g., for time periods of less than one second, one second, one to five seconds, more than five seconds, or the like). The devices that communicate with the BG monitoring system 20 “wake up” at the fixed intervals and “listen” to receive the information from the BG monitoring system 20. This fixed interval communication method allows the BG monitoring system 20 and the devices that communicate with the BG monitoring system 20 to supply power to their communication systems on a periodic, rather than continuous, basis. Accordingly, the BG monitoring system 20 and the devices that communicate with the BG monitoring system 20 are able to save power when not communicating with one another. In alternative embodiments, the BG monitoring system 20 and the devices that communicate with the BG monitoring system 20 may supply power to their communication systems on a continuous basis, and thus, be capable of continuous communication. In further alternative embodiments, the BG monitoring system 20 and the devices that communicate with the BG monitoring system 20 may supply power to their communication systems only upon request from the user. For example, the user may select the dedicated key 122 on the infusion pump 30 shown in FIG. 3(a), or alternatively, the dedicated key 212 or 226 on the relay device 10 shown in FIGS. 6(c) and 6(d), to request information from the BG monitoring system 20. The BG monitoring system 20 may periodically supply power to its communication system for a relatively short time period in order to detect whether another device is requesting information, and in response to such a request, the BG monitoring system 20 and the devices that communicate with the BG monitoring system 20 may supply power to their communication systems and then communicate the requested information. Accordingly, the BG monitoring system 20 and the devices that communicate with the BG monitoring system 20 are able to save power when not communicating with one another.
  • [0092]
    Referring to FIG. 1, the relay device 10 receives information from the BG monitoring system 20, and then transmits the information to the infusion pump 30. The relay device 10 may also receive information from the infusion pump 30, and then transmit the information to the BG monitoring system 20. In preferred embodiments, the infusion pump 30 includes a display 32 and a user interface 34, as shown in FIG. 4(a). For example, the display 32 may be an LCD display 100, and the user interface 34 may be a keypad 10 including one or more keys, as shown in FIGS. 3(a)-3(b). The BG monitoring system 20 sends a sensor signal to the relay device 10, and then the relay device 10 sends the sensor signal to the infusion pump 30. In preferred embodiments, the sensor signal contains uncalibrated sensor data, and the infusion pump 30 calibrates the uncalibrated sensor data to generate sensor measurements, which are shown on the display 32. In particular embodiments, the BG monitoring system automatically sends the sensor data to the infusion pump 30 on a periodic (e.g., once every thirty seconds, minute, five minutes, ten minutes, or the like) or continuous basis, and the infusion pump 30 automatically shows the sensor measurement on the display 32 once the sensor data has been received and calibrated. The user may also utilize the user interface 34 to cause the display 32 to show a sensor measurement. In other particular embodiments, once the infusion pump 30 generates the sensor measurement, the infusion pump 30 may provide an alarm or warning to the user if the sensor measurement is above or below target glycemic values. For example, if the sensor measurement is above a hyperglycemic limit (e.g., 250 mg/dl) or below a hypoglycemic limit (e.g., 70 mg/dl), the infusion pump 30 may provide the user with a visible alarm via the display 100 and/or lights, an audible alarm via the speaker 156, and/or a vibration alarm via the vibrator 158. The infusion pump 30 may also suspend insulin delivery if the sensor measurement is below the hypoglycemic limit, and notify the user to activate a bolus delivery if the sensor measurement is above the hyperglycemic limit. In further particular embodiments, the infusion pump 30 may include the bolus estimator 164, which utilizes the sensor measurement to estimate an appropriate amount of insulin to be delivered to the user based on the user's BG level, the amount of carbohydrates to be consumed, and the like. The calculated bolus estimate may be shown to the user on the display 32, and the user may then utilize the user interface 34 to accept or modify the bolus estimate for infusion into the user. In alternative embodiments, the BG monitoring system 20 calibrates the sensor data to generate sensor measurements, which are included in the sensor signal transmitted from the BG monitoring system 20 to the infusion pump 30 via the relay device 10. In other alternative embodiments, the BG monitoring system 20 sends a sensor signal with uncalibrated sensor data to the relay device 10, the relay device 10 calibrates the uncalibrated sensor data to generate sensor measurements, and the relay device 10 sends the sensor signal with the sensor measurements to the infusion pump 30.
  • [0093]
    In additional alternative embodiments, the infusion pump 30 may include a display 32, and the relay device 10 may include a user interface 14, as shown in FIG. 4(b). For example, the display 32 may be an LCD display 100 (as shown in FIGS. 3(a)-3(b)), and the user interface 14 may be a single key 202 (as shown in FIG. 6(b)), or a keypad 204 or 216 including one or more keys (as shown in FIGS. 6(c) and 6(d)). The user may utilize the user interface 14 on the relay device 10 to request new data from the BG monitoring system 20. When the user interface 14 is activated (e.g., the user presses the single key 202 shown in FIG. 6(b), one or more keys on the keypad 204 shown in FIG. 6(c), or one or more keys on the keypad 216 shown in FIG. 6(d)), the relay device 10 sends a request to the BG monitoring system 20 to transmit the most recent sensor data, as shown in FIG. 4(b). In other alternative embodiments, when the user interface 14 is activated, the relay device 10 sends a signal to the infusion pump 30 to request the most recent sensor data from the BG monitoring system 20, and the infusion pump 30 then sends such a request to the BG monitoring system 20 through the relay device 10, as shown in FIG. 4(c). Referring to FIGS. 4(b) and 4(c), in response to a request for the most recent sensor data, the BG monitoring system 20 sends a sensor signal to the relay device 10, and then the relay device 10 sends the sensor signal to the infusion pump 30, similar to the manner described above with respect to FIG. 4(a). In particular embodiments, the infusion pump 30 may automatically show a sensor measurement on the display 32 once the sensor signal is received by the infusion pump 30. The user may also utilize the user interface 14 on the relay device 10 to cause the display 32 on the infusion pump 30 to show a sensor measurement. The user may also utilize the user interface 14 on the relay device 10 to send commands or data to the infusion pump 30.
  • [0094]
    In further alternative embodiments, the relay device 10 may include a first user interface 14′, and the infusion pump 30 may include a display 32 and a second user interface 34′, as shown in FIG. 4(f). The user may utilize the first user interface 14′ on the relay device 10 to request new data from the BG monitoring system 20. When the first user interface 14′ is activated, the relay device 10 sends a request to the BG monitoring system 20 to transmit the most recent sensor data. In response, the BG monitoring system 20 sends a sensor signal to the relay device 10, and then the relay device 10 sends the sensor signal to the infusion pump 30, similar to the manner described above with respect to FIG. 4(a). In particular embodiments, the infusion pump 30 may automatically show a sensor measurement on the display 32′ once the sensor signal is received by the infusion pump 30. The user may also utilize the first user interface 14′ on the relay device 10 or the second user interface 34′ on the infusion pump 30 to cause the display 32 on the infusion pump 30 to show a sensor measurement. The user may additionally utilize the first user interface 14′ on the relay device 10 to send commands or data to the infusion pump 30. Further, the user may utilize the second user interface 34′ on the infusion pump 30 to perform functions on the infusion pump 30.
  • [0095]
    In other alternative embodiments, the relay device 10 may include a display 12 and a user interface 14, as shown in FIG. 4(d). For example, the display 12 may be an LCD display 214, and the user interface 14 may be a keypad 216 including one or more keys, as illustrated in FIG. 6(d). The BG monitoring system 20 sends a sensor signal with uncalibrated sensor data to the relay device 10, and the relay device 10 calibrates the data to generate sensor measurements, which are shown on the display 12 of the relay device 10. In particular embodiments, the relay device 10 may automatically show a sensor measurement on the display 12 once the sensor data is received and calibrated by the relay device 10. The user may also utilize the user interface 14 to cause the display 12 to show a sensor measurement. The user may further utilize the user interface 14 on the relay device 10 to send commands or data to the infusion pump 30. In particular embodiments, the relay device 10 may also receive data from the infusion pump 30 (not shown), such as the amount of insulin remaining, alarms indicating a low battery or no delivery by the infusion pump 30, and the like. The relay device 10 may then utilize such data to adjust the commands sent to the infusion pump 30 and/or show such data on the display 12 to the user. In alternative embodiments, the BG monitoring system 20 calibrates the sensor data to generate sensor measurements, which are included in the sensor signal transmitted from the BG monitoring system 20 to the relay device 10.
  • [0096]
    In still other alternative embodiments, the BG monitoring system 20 includes a display 22 and a user interface 24, as shown in FIG. 4(e). For example, the display 22 may be an LCD display 58, and the user interface 24 may be a keypad 60 including one or more keys, as shown in FIGS. 2(a)-2(c). The BG monitoring system 20 calibrates the sensor data to generate sensor measurements, which are shown on the display 22 of the BG monitoring system 20. In particular embodiments, the BG monitoring system 20 may automatically show a sensor measurement on the display 22 once the sensor data is calibrated. The user may also utilize the user interface 24 to cause the display 22 to show a sensor measurement. The user may further utilize the user interface 24 on the BG monitoring system 20 to send commands or data through the relay device 10 to the infusion pump 30.
  • [0097]
    In preferred embodiments, the BG monitoring system 20 sends a sensor signal to the relay device 10, and then the relay device 10 sends the sensor signal to the infusion pump 30, as shown in FIG. 4(a). The infusion pump 30 includes a display 32 and a user interface 34, such as the display 100 and user interface 110 shown in FIG. 3(a). In particular embodiments, the BG monitoring system automatically sends the sensor signal to the infusion pump 30 on a periodic (e.g., once every thirty seconds, minute, five minutes, ten minutes, or the like) or continuous basis. In other particular embodiments, the infusion pump 30 periodically sends a command signal to the BG monitoring system 20 via the relay device 10, commanding the BG monitoring system 20 to send the sensor signal to the infusion pump 30, and in response to the command, the BG monitoring system 20 sends the sensor signal to the infusion pump 30. In further particular embodiments, the user interface 110 may be utilized to cause the BG monitoring system 20 to send the sensor signal to the infusion pump 30 via the relay device 10. In preferred embodiments, the infusion pump 30 automatically shows a sensor measurement on the display 32 once the sensor signal is received by the infusion pump 30. The user may also utilize the user interface 110 to cause the display 100 to show a sensor measurement.
  • [0098]
    The user interface 110 on the infusion pump 30 preferably includes a dedicated interface for requesting information from and/or inputting data to the BG monitoring system 20 via the relay device 10. Additionally, in particular embodiments where bidirectional communication is not enabled continuously between the BG monitoring system 20 and the infusion pump 30, utilizing the dedicated interface may initiate bi-directional communication between the infusion pump 30 and the BG monitoring system 20 via the relay device 10. In further particular embodiments, the dedicated interface may be used to cause the display 100 of the infusion pump 30 to show historical data, such as trends of whether sensor measurements are increasing or decreasing, a plot of two or more sensor measurements, a graph of the past n-hours of sensor measurements, and the like. In other embodiments, the infusion pump 30 may automatically show sensor measurements or historical data (e.g., trends, plots, graphs, or the like of sensor measurements) on the display 100 when the display 100 would otherwise be blank.
  • [0099]
    Referring to FIG. 3(a), the dedicated interface on the infusion pump 30 may include a dedicated key 122 for causing the display 100 to show the sensor measurement. In alternative embodiments, the user may select one or more keystrokes to cause the display 100 to show the sensor measurement. For example, the user may select the dedicated key 122 followed by the ACT key 116 to cause the display 100 to show the sensor measurement. In further alternative embodiments, the ability of the infusion pump 30 to communicate with the BG monitoring system 20 via the relay device 10 may be activated by entering the BG monitoring system's 20 serial number or other identifying information into the infusion pump 30. In response, the infusion pump 30 may program certain keys for interfacing with the BG monitoring system 20 via the relay device 10.
  • [0100]
    In other alternative embodiments, the dedicated interface may include a button, switch, lever, handle, touch screen, or the like, or combinations of keys, buttons, switches, levers, handles, touch screens, or the like. Combinations of interfaces include activating more than one interface simultaneously (in parallel), or activating more than one interface in sequence. In still other alternative embodiments, the dedicated interface may be located on another device that communicates with the infusion pump 30, and the sensor measurement may be shown on a display of that device, such as the BG monitoring system 20 (for example, the glucose monitor 54 and/or data processor 56), a remote programmer (not shown) for the infusion pump 30, a personal digital assistant (PDA), a computer, a cell phone, or the like.
  • [0101]
    In preferred embodiments, one or more sensor measurements are stored in the memory 154 of the infusion pump 30. Furthermore, selecting the dedicated key 122 (or other dedicated interface) causes the most recent sensor measurement to be shown on the display 100. When the most recent sensor measurement is already shown on the display 100, selecting the dedicated key 122 causes the next, most recent sensor measurement to be shown on the display 100, and each subsequent selection of the dedicated key 122 causes older and older sensor measurements to be shown on the display 100. In alternative embodiments, the infusion pump 30 may include other user interfaces to display older sensor measurements. In other alternative embodiments, the sensor measurements may be stored in a storage device other than the infusion pump 30, and selecting the dedicated key 122 causes the infusion pump 30 to retrieve the sensor measurement from the storage device and then show it on the display 100.
  • [0102]
    In additional alternative embodiments, the infusion pump 30 periodically sends a command signal to the BG monitoring system 20 via the relay device 10, commanding the BG monitoring system 20 to send sensor data to the infusion pump 30, so that the most recent sensor data is available to be shown on the display 100 of the infusion pump 30. In response to the command from the infusion pump 30, the BG monitoring system 20 sends the sensor data to the infusion pump 30, and the infusion pump 30 calibrates the sensor data to generate a sensor measurement. The sensor measurement is then stored in the memory 154 of the infusion pump 30. When the user desires to see the most recent sensor measurement, the user selects the dedicated key 122 (or other)dedicated interface) to retrieve the sensor measurement from the memory 154 of the infusion pump 30 and show the sensor measurement on the display 100 of the infusion pump 30. In other alternative embodiments, the sensor data is stored in the memory 154 of the infusion pump 30. When the user selects the dedicated key 122 to view the sensor measurement, the sensor data is retrieved from the memory 154 of the infusion pump 30, and then calibrated to generate the sensor measurement. In further alternative embodiments, the BG monitoring system 20 sends calibrated sensor measurements to be stored in the memory 154 of the infusion pump 30. In yet other alternative embodiments, the infusion pump 30 communicates with the BG monitoring system 20 to indicate that the sensor data has been received and/or to echo the sensor data so that the data can be retransmitted if it was received inaccurately.
  • [0103]
    In still other alternative embodiments, the dedicated key 122 (or other dedicated interface) is used to cause the BG monitoring system 20 to send the most recent sensor data, such as one or more raw sensor data points, one or more calibrated sensor measurements, or the like, to the infusion pump 30. Once the sensor data is received, the infusion pump 30 shows the most recent sensor measurement on the display 100. In particular alternative embodiments, the infusion pump 30 indicates to the BG monitoring system 20 the most recent sensor data that the infusion pump 30 has received, and in response, the BG monitoring system 20 sends any additional sensor data that the BG monitoring system 20 has that has not been received by the infusion pump 30.
  • [0104]
    In another embodiment of the present invention, the BG level measured by the BG monitoring system 20 is used in a closed loop algorithm to automatically adjust the delivery of fluid, such as insulin, in the infusion pump 30. A calibration algorithm is used to convert sensor data into sensor measurements, and then the sensor measurements are used in a closed loop algorithm to generate fluid delivery commands to operate the infusion pump 30. In particular embodiments, the calibration algorithm 26 and closed loop algorithm 28 reside with and are executed by the processor of the BG monitoring system 20, as shown in FIG. 5(a). Commands to control the infusion pump 30 are generated at the BG monitoring system 20, and are sent through the relay device 10 to the infusion pump 30.
  • [0105]
    In other particular embodiments, the calibration algorithm 26 resides with and is executed by the processor of the BG monitoring system 20, and the closed loop algorithm 18 resides with and is executed by the processor of the relay device 10, as shown in FIG. 5(b). Calibrated sensor measurements are sent from the BG monitoring system 20 to the relay device 10, and fluid delivery commands are sent from the relay device to the infusion pump 30.
  • [0106]
    In still other particular embodiments, the calibration algorithm 26 resides with and is executed by the processor of the BG monitoring system 20, and the closed loop algorithm 38 resides with and is executed by the processor of the infusion pump 30, as shown in FIG. 5(c). Calibrated sensor measurements are sent from the BG monitoring system 20 through the relay device 10 to the infusion pump 30, and fluid delivery commands are generated at the infusion pump 30.
  • [0107]
    In yet other particular embodiments, the calibration algorithm 16 and the closed loop algorithm 18 both reside with and are executed by the processor of the relay device 10, as shown in FIG. 5(d). Uncalibrated sensor data is sent from the BG monitoring system 20 to the relay device 10, where they are calibrated and used in the closed loop algorithm 18 to generate fluid delivery commands, which are sent to the infusion pump 30.
  • [0108]
    In further particular embodiments, the calibration algorithm 16 resides with and is executed by the processor of the relay device 10, and the closed loop algorithm 38 resides with and is executed by the processor of the infusion pump 30, as shown in FIG. 5(e). Uncalibrated sensor data is sent from the BG monitoring system 20 to the relay device 10, where they are calibrated to generate sensor measurements. Then the sensor measurements are sent to the infusion pump 30 and used in the closed loop algorithm 38 to generate fluid delivery commands.
  • [0109]
    In additional particular embodiments, the calibration algorithm 36 and the closed loop algorithm 38 both reside with and are executed by the processor of the infusion pump 30, as shown in FIG. 5(f). Uncalibrated sensor data is sent from the BG monitoring system 20 through the relay device 10 to the infusion pump 30. Then, at the infusion pump 30, the uncalibrated sensor data is calibrated and used in the closed loop algorithm 38 to generate fluid delivery commands.
  • [0110]
    In alternative embodiments, a semi-closed loop algorithm is used in place of a closed loop algorithm. A semi-closed loop algorithm generates recommended changes to the fluid delivery, which must be approved by the user or a caregiver using the user interface on the infusion pump 30, the BG monitoring system 20, or the relay device 10 before new commands are issued to the infusion pump 30.
  • [0111]
    Although FIGS. 4(a)-5(f) generally show communication flowing from the BG monitoring system 20 to the infusion pump 30, it should be noted that communication signals might be generated by any of the devices. In particular embodiments, a signal may be sent from the infusion pump 30 through the relay device 10 to the BG monitoring system 20. The signals from the infusion pump 30 may include signals to request information from the BG monitoring system 20, verify receipt of information, echo information received, transmit information to be downloaded to the BG monitoring system 20, and the like. In additional alternative embodiments, signals may be initiated at the relay device 10 and sent to the BG monitoring system 20 and/or the infusion pump 30.
  • [0112]
    While the description above refers to particular embodiments of the present invention, it will be understood that many modifications may be made without departing from the spirit thereof. The accompanying claims are intended to cover such modifications as would fall within the true scope and spirit of the present invention.
  • [0113]
    The presently disclosed embodiments are therefore to be considered in all respects as illustrative and not restrictive, the scope of the invention being indicated by the appended claims, rather than the foregoing description, and all changes which come within the meaning and range of equivalency of the claims are therefore intended to be embraced therein.
Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
US3631847 *Mar 25, 1969Jan 4, 1972James C HobbsMethod and apparatus for injecting fluid into the vascular system
US4212738 *Mar 23, 1978Jul 15, 1980Akzo N.V.Artificial kidney
US4270532 *Dec 13, 1978Jun 2, 1981Siemens AktiengesellschaftDevice for the pre-programmable infusion of liquids
US4373527 *Apr 27, 1979Feb 15, 1983The Johns Hopkins UniversityImplantable, programmable medication infusion system
US4395259 *Sep 14, 1981Jul 26, 1983Siemens AktiengesellschaftDevice for the infusion of fluids into the human or animal body
US4433072 *Apr 29, 1983Feb 21, 1984Hospal-Sodip, S.A.Mixtures of polymers for medical use
US4443218 *Sep 9, 1982Apr 17, 1984Infusaid CorporationProgrammable implantable infusate pump
US4494950 *Jan 19, 1982Jan 22, 1985The Johns Hopkins UniversityPlural module medication delivery system
US4562751 *Jan 6, 1984Jan 7, 1986Nason Clyde KSolenoid drive apparatus for an external infusion pump
US4671288 *Jun 13, 1985Jun 9, 1987The Regents Of The University Of CaliforniaElectrochemical cell sensor for continuous short-term use in tissues and blood
US4678408 *Sep 24, 1985Jul 7, 1987Pacesetter Infusion, Ltd.Solenoid drive apparatus for an external infusion pump
US4731051 *Feb 15, 1983Mar 15, 1988The Johns Hopkins UniversityProgrammable control means for providing safe and controlled medication infusion
US4731726 *May 19, 1986Mar 15, 1988Healthware CorporationPatient-operated glucose monitor and diabetes management system
US4803625 *Jun 30, 1986Feb 7, 1989Buddy Systems, Inc.Personal health monitor
US4809697 *Oct 14, 1987Mar 7, 1989Siemens-Pacesetter, Inc.Interactive programming and diagnostic system for use with implantable pacemaker
US4826810 *Mar 19, 1987May 2, 1989Aoki Thomas TSystem and method for treating animal body tissues to improve the dietary fuel processing capabilities thereof
US4898578 *Jan 26, 1988Feb 6, 1990Baxter International Inc.Drug infusion system with calculator
US4935105 *Oct 18, 1989Jun 19, 1990Imperial Chemical Industries PlcMethods of operating enzyme electrode sensors
US5003298 *Jul 14, 1989Mar 26, 1991Karel HavelVariable color digital display for emphasizing position of decimal point
US5011468 *Apr 16, 1990Apr 30, 1991Retroperfusion Systems, Inc.Retroperfusion and retroinfusion control apparatus, system and method
US5019974 *Feb 22, 1990May 28, 1991Diva Medical Systems BvDiabetes management system and apparatus
US5078683 *May 4, 1990Jan 7, 1992Block Medical, Inc.Programmable infusion system
US5080653 *Apr 16, 1990Jan 14, 1992Pacesetter Infusion, Ltd.Infusion pump with dual position syringe locator
US5097122 *Apr 16, 1990Mar 17, 1992Pacesetter Infusion, Ltd.Medication infusion system having optical motion sensor to detect drive mechanism malfunction
US5100380 *May 16, 1989Mar 31, 1992Abbott LaboratoriesRemotely programmable infusion system
US5101814 *Aug 11, 1989Apr 7, 1992Palti Yoram ProfSystem for monitoring and controlling blood glucose
US5108819 *Feb 14, 1990Apr 28, 1992Eli Lilly And CompanyThin film electrical component
US5284140 *Feb 11, 1992Feb 8, 1994Eli Lilly And CompanyAcrylic copolymer membranes for biosensors
US5299571 *Jan 22, 1993Apr 5, 1994Eli Lilly And CompanyApparatus and method for implantation of sensors
US5307263 *Nov 17, 1992Apr 26, 1994Raya Systems, Inc.Modular microprocessor-based health monitoring system
US5317506 *May 12, 1992May 31, 1994Abbott LaboratoriesInfusion fluid management system
US5320725 *May 8, 1992Jun 14, 1994E. Heller & CompanyElectrode and method for the detection of hydrogen peroxide
US5322063 *Oct 4, 1991Jun 21, 1994Eli Lilly And CompanyHydrophilic polyurethane membranes for electrochemical glucose sensors
US5390671 *Mar 15, 1994Feb 21, 1995Minimed Inc.Transcutaneous sensor insertion set
US5391250 *Mar 15, 1994Feb 21, 1995Minimed Inc.Method of fabricating thin film sensors
US5403700 *Jan 22, 1992Apr 4, 1995Eli Lilly And CompanyMethod of making a thin film electrical component
US5411647 *Jan 25, 1994May 2, 1995Eli Lilly And CompanyTechniques to improve the performance of electrochemical sensors
US5417222 *Jan 21, 1994May 23, 1995Hewlett-Packard CompanyPatient monitoring system
US5482473 *May 9, 1994Jan 9, 1996Minimed Inc.Flex circuit connector
US5485408 *Jul 15, 1994Jan 16, 1996Sims Deltec, Inc.Pump simulation apparatus
US5497772 *Nov 19, 1993Mar 12, 1996Alfred E. Mann Foundation For Scientific ResearchGlucose monitoring system
US5507288 *May 3, 1995Apr 16, 1996Boehringer Mannheim GmbhAnalytical system for monitoring a substance to be analyzed in patient-blood
US5593390 *Feb 28, 1995Jan 14, 1997Visionary Medical Products, Inc.Medication delivery device with a microprocessor and characteristic monitor
US5593852 *Sep 1, 1994Jan 14, 1997Heller; AdamSubcutaneous glucose electrode
US5594638 *Dec 29, 1993Jan 14, 1997First Opinion CorporationComputerized medical diagnostic system including re-enter function and sensitivity factors
US5609060 *Apr 28, 1995Mar 11, 1997Dentsleeve Pty LimitedMultiple channel perfused manometry apparatus and a method of operation of such a device
US5626144 *Dec 22, 1995May 6, 1997Enact Health Management SystemsSystem for monitoring and reporting medical measurements
US5630710 *Mar 9, 1994May 20, 1997Baxter International Inc.Ambulatory infusion pump
US5643212 *Mar 7, 1994Jul 1, 1997Coutre; James E.Infusion pump management system for suggesting an adapted course of therapy
US5704366 *May 23, 1994Jan 6, 1998Enact Health Management SystemsSystem for monitoring and reporting medical measurements
US5750926 *Aug 16, 1995May 12, 1998Alfred E. Mann Foundation For Scientific ResearchHermetically sealed electrical feedthrough for use with implantable electronic devices
US5764159 *Feb 15, 1995Jun 9, 1998Debiotech S.A.Apparatus for remotely monitoring controllable devices
US5772635 *May 15, 1995Jun 30, 1998Alaris Medical Systems, Inc.Automated infusion system with dose rate calculator
US5777060 *Sep 26, 1996Jul 7, 1998Minimed, Inc.Silicon-containing biocompatible membranes
US5779665 *May 8, 1997Jul 14, 1998Minimed Inc.Transdermal introducer assembly
US5786439 *Oct 24, 1996Jul 28, 1998Minimed Inc.Hydrophilic, swellable coatings for biosensors
US5861018 *May 28, 1996Jan 19, 1999Telecom Medical Inc.Ultrasound transdermal communication system and method
US5868669 *Jan 9, 1997Feb 9, 1999First Opinion CorporationComputerized medical diagnostic and treatment advice system
US5871465 *Jun 5, 1996Feb 16, 1999I-Flow CorporationRemotely programmable infusion system
US5879163 *Jun 24, 1996Mar 9, 1999Health Hero Network, Inc.On-line health education and feedback system using motivational driver profile coding and automated content fulfillment
US5885245 *Oct 16, 1997Mar 23, 1999Sabratek CorporationMedical apparatus with remote virtual input device
US5897493 *Apr 30, 1997Apr 27, 1999Health Hero Network, Inc.Monitoring system for remotely querying individuals
US5899855 *Jun 7, 1995May 4, 1999Health Hero Network, Inc.Modular microprocessor-based health monitoring system
US5904708 *Mar 19, 1998May 18, 1999Medtronic, Inc.System and method for deriving relative physiologic signals
US5913310 *Oct 29, 1997Jun 22, 1999Health Hero Network, Inc.Method for diagnosis and treatment of psychological and emotional disorders using a microprocessor-based video game
US5917346 *Sep 12, 1997Jun 29, 1999Alfred E. Mann FoundationLow power current to frequency converter circuit for use in implantable sensors
US5918603 *May 15, 1997Jul 6, 1999Health Hero Network, Inc.Method for treating medical conditions using a microprocessor-based video game
US6032119 *Jan 16, 1997Feb 29, 2000Health Hero Network, Inc.Personalized display of health information
US6043437 *Dec 19, 1997Mar 28, 2000Alfred E. Mann FoundationAlumina insulation for coating implantable components and other microminiature devices
US6081736 *Oct 20, 1997Jun 27, 2000Alfred E. Mann FoundationImplantable enzyme-based monitoring systems adapted for long term use
US6175752 *Apr 30, 1998Jan 16, 2001Therasense, Inc.Analyte monitoring device and methods of use
US6183412 *Oct 2, 1998Feb 6, 2001Micromed Technology, Inc.Implantable pump system
US6246992 *Sep 14, 1998Jun 12, 2001Health Hero Network, Inc.Multiple patient monitoring system for proactive health management
US6248067 *Feb 5, 1999Jun 19, 2001Minimed Inc.Analyte sensor and holter-type monitor system and method of using the same
US6408330 *Oct 13, 1998Jun 18, 2002Delahuerga CarlosRemote data collecting and address providing method and apparatus
US6503381 *Sep 18, 2000Jan 7, 2003Therasense, Inc.Biosensor
US6514718 *Nov 29, 2001Feb 4, 2003Therasense, Inc.Subcutaneous glucose electrode
US6554798 *Jun 16, 1999Apr 29, 2003Medtronic Minimed, Inc.External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities
US6558320 *Jan 20, 2000May 6, 2003Medtronic Minimed, Inc.Handheld personal data assistant (PDA) with a medical device and method of using the same
US6560741 *Feb 24, 1999May 6, 2003Datastrip (Iom) LimitedTwo-dimensional printed code for storing biometric information and integrated off-line apparatus for reading same
US6565509 *Sep 21, 2000May 20, 2003Therasense, Inc.Analyte monitoring device and methods of use
US6579690 *Oct 4, 1998Jun 17, 2003Therasense, Inc.Blood analyte monitoring through subcutaneous measurement
US6676816 *May 9, 2002Jan 13, 2004Therasense, Inc.Transition metal complexes with (pyridyl)imidazole ligands and sensors using said complexes
US6689265 *Mar 23, 2001Feb 10, 2004Therasense, Inc.Electrochemical analyte sensors using thermostable soybean peroxidase
US6733471 *Sep 15, 2000May 11, 2004Medtronic, Inc.Hemostatic system and components for extracorporeal circuit
US6746582 *May 11, 2001Jun 8, 2004Therasense, Inc.Electrodes with multilayer membranes and methods of making the electrodes
US6749740 *Dec 28, 2001Jun 15, 2004Therasense, Inc.Small volume in vitro analyte sensor and methods
US6881551 *Jan 28, 2003Apr 19, 2005Therasense, Inc.Subcutaneous glucose electrode
US6893545 *Nov 25, 2002May 17, 2005Therasense, Inc.Biosensor
US20020082665 *Jan 18, 2001Jun 27, 2002Medtronic, Inc.System and method of communicating between an implantable medical device and a remote computer system or health care provider
US20030061232 *Sep 21, 2001Mar 27, 2003Dun & Bradstreet Inc.Method and system for processing business data
US20030061234 *Sep 25, 2001Mar 27, 2003Ali Mohammed ZamshedApplication location register routing
US20030078560 *Dec 27, 2001Apr 24, 2003Miller Michael E.Method and system for non-vascular sensor implantation
US20030088166 *Nov 11, 2002May 8, 2003Therasense, Inc.Electrochemical analyte sensor
US20040064133 *Dec 31, 2002Apr 1, 2004Medtronic-MinimedImplantable sensor method and system
US20040064156 *Dec 31, 2002Apr 1, 2004Medtronic Minimed, Inc.Method and apparatus for enhancing the integrity of an implantable sensor device
US20040074785 *Oct 18, 2002Apr 22, 2004Holker James D.Analyte sensors and methods for making them
US20040093167 *Nov 8, 2002May 13, 2004Braig James R.Analyte detection system with software download capabilities
US20040111017 *Nov 25, 2003Jun 10, 2004Therasense, Inc.Mass transport limited in vivo analyte sensor
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US7091848Dec 14, 2004Aug 15, 2006Alford Safety Services, Inc.Enclosure system for hot work within the vicinity of flammable or combustible material
US7193501Jul 7, 2005Mar 20, 2007Alford Safety Services, Inc.Enclosure system allowing for hot work within the vicinity of flammable and combustible material
US7231263 *Oct 10, 2006Jun 12, 2007Soo Bong ChoiMethod for controlling insulin pump through internet
US7518484 *Nov 29, 2006Apr 14, 2009Alford Safety Services, Inc.Enclosure system allowing for hot work within the vicinity of flammable and combustible material
US7545272Feb 7, 2006Jun 9, 2009Therasense, Inc.RF tag on test strips, test strip vials and boxes
US7603186Apr 28, 2006Oct 13, 2009Advanced Energy Industries, Inc.Adaptive response time closed loop control algorithm
US7653425Jan 26, 2010Abbott Diabetes Care Inc.Method and system for providing calibration of an analyte sensor in an analyte monitoring system
US7679407Apr 27, 2004Mar 16, 2010Abbott Diabetes Care Inc.Method and apparatus for providing peak detection circuitry for data communication systems
US7697967Sep 28, 2006Apr 13, 2010Abbott Diabetes Care Inc.Method and apparatus for providing analyte sensor insertion
US7722536Jul 14, 2004May 25, 2010Abbott Diabetes Care Inc.Glucose measuring device integrated into a holster for a personal area network device
US7727181Apr 13, 2005Jun 1, 2010Abbott Diabetes Care Inc.Fluid delivery device with autocalibration
US7727222May 20, 2008Jun 1, 2010Plc Medical Systems, Inc.Patient hydration system with taper down feature
US7731657Aug 30, 2005Jun 8, 2010Abbott Diabetes Care Inc.Analyte sensor introducer and methods of use
US7736310Jan 30, 2006Jun 15, 2010Abbott Diabetes Care Inc.On-body medical device securement
US7736354Apr 21, 2006Jun 15, 2010Plc Medical Systems, Inc.Patient hydration system with hydration state detection
US7753873 *Dec 29, 2008Jul 13, 2010Abbott Diabetes Care Inc.Fluid delivery device with autocalibration
US7753874 *Jul 13, 2010Abbott Diabetes Care Inc.Fluid delivery device with autocalibration
US7756561Sep 30, 2005Jul 13, 2010Abbott Diabetes Care Inc.Method and apparatus for providing rechargeable power in data monitoring and management systems
US7758562Jul 20, 2010Plc Medical Systems, Inc.Patient hydration system with a redundant monitoring of hydration fluid infusion
US7758563Jul 20, 2010Plc Medical Systems, Inc.Patient hydration monitoring and maintenance system and method for use with administration of a diuretic
US7766829Nov 4, 2005Aug 3, 2010Abbott Diabetes Care Inc.Method and system for providing basal profile modification in analyte monitoring and management systems
US7766864 *Dec 29, 2008Aug 3, 2010Abbott Diabetes Care Inc.Fluid delivery device with autocalibration
US7768386Jul 31, 2007Aug 3, 2010Abbott Diabetes Care Inc.Method and apparatus for providing data processing and control in a medical communication system
US7768387Apr 14, 2008Aug 3, 2010Abbott Diabetes Care Inc.Method and apparatus for providing dynamic multi-stage signal amplification in a medical device
US7768408May 17, 2006Aug 3, 2010Abbott Diabetes Care Inc.Method and system for providing data management in data monitoring system
US7801582Mar 31, 2006Sep 21, 2010Abbott Diabetes Care Inc.Analyte monitoring and management system and methods therefor
US7811231Oct 12, 2010Abbott Diabetes Care Inc.Continuous glucose monitoring system and methods of use
US7822455Oct 26, 2010Abbott Diabetes Care Inc.Analyte sensors and methods of use
US7826382Nov 2, 2010Abbott Diabetes Care Inc.Close proximity communication device and methods
US7826879Feb 28, 2006Nov 2, 2010Abbott Diabetes Care Inc.Analyte sensors and methods of use
US7837667Nov 23, 2010Plc Medical Systems, Inc.Patient hydration system with abnormal condition sensing
US7860544Mar 7, 2007Dec 28, 2010Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US7869853Jan 11, 2011Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US7883464Sep 30, 2005Feb 8, 2011Abbott Diabetes Care Inc.Integrated transmitter unit and sensor introducer mechanism and methods of use
US7884729Aug 2, 2010Feb 8, 2011Abbott Diabetes Care Inc.Method and system for providing data management in data monitoring system
US7885698Feb 28, 2006Feb 8, 2011Abbott Diabetes Care Inc.Method and system for providing continuous calibration of implantable analyte sensors
US7885699Feb 8, 2011Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US7892197Feb 22, 2011Fresenius Medical Care Holdings, Inc.Automatic prime of an extracorporeal blood circuit
US7920907Jun 7, 2007Apr 5, 2011Abbott Diabetes Care Inc.Analyte monitoring system and method
US7922458Dec 29, 2008Apr 12, 2011Abbott Diabetes Care Inc.Variable volume, shape memory actuated insulin dispensing pump
US7928850Apr 19, 2011Abbott Diabetes Care Inc.Analyte monitoring system and methods
US7938817Sep 9, 2004May 10, 2011Plc Medical Systems, Inc.Patient hydration system and method
US7942844May 17, 2011Medtronic Minimed, Inc.Remote monitoring for networked fluid infusion systems
US7948369Aug 2, 2010May 24, 2011Abbott Diabetes Care Inc.Method and apparatus for providing dynamic multi-stage signal amplification in a medical device
US7948370Aug 14, 2009May 24, 2011Abbott Diabetes Care Inc.Method and apparatus for providing data communication in data monitoring and management systems
US7951080May 31, 2011Abbott Diabetes Care Inc.On-body medical device securement
US7976778Jul 12, 2011Abbott Diabetes Care Inc.Blood glucose tracking apparatus
US7993108Aug 9, 2011Abbott Diabetes Care Inc.Variable volume, shape memory actuated insulin dispensing pump
US7993109Aug 9, 2011Abbott Diabetes Care Inc.Variable volume, shape memory actuated insulin dispensing pump
US7996158May 14, 2008Aug 9, 2011Abbott Diabetes Care Inc.Method and apparatus for providing data processing and control in a medical communication system
US8007460May 20, 2010Aug 30, 2011Plc Medical Systems, Inc.Patient hydration system and method
US8029245Oct 4, 2011Abbott Diabetes Care Inc.Variable volume, shape memory actuated insulin dispensing pump
US8029250Oct 4, 2011Abbott Diabetes Care Inc.Variable volume, shape memory actuated insulin dispensing pump
US8029441Feb 28, 2006Oct 4, 2011Abbott Diabetes Care Inc.Analyte sensor transmitter unit configuration for a data monitoring and management system
US8029443Sep 26, 2008Oct 4, 2011Abbott Diabetes Care Inc.Glucose measuring device integrated into a holster for a personal area network device
US8029459Oct 4, 2011Abbott Diabetes Care Inc.Method and system for providing integrated medication infusion and analyte monitoring system
US8029460Oct 4, 2011Abbott Diabetes Care Inc.Method and system for providing integrated medication infusion and analyte monitoring system
US8047811Dec 29, 2008Nov 1, 2011Abbott Diabetes Care Inc.Variable volume, shape memory actuated insulin dispensing pump
US8047812Dec 29, 2008Nov 1, 2011Abbott Diabetes Care Inc.Variable volume, shape memory actuated insulin dispensing pump
US8062253Apr 25, 2006Nov 22, 2011Novo Nordisk A/SMedical skin mountable device
US8066639Jun 4, 2004Nov 29, 2011Abbott Diabetes Care Inc.Glucose measuring device for use in personal area network
US8073008Feb 5, 2007Dec 6, 2011Medtronic Minimed, Inc.Subnetwork synchronization and variable transmit synchronization techniques for a wireless medical device network
US8075513Dec 13, 2011Plc Medical Systems, Inc.Patient connection system for a balance hydration unit
US8086292Oct 27, 2009Dec 27, 2011Abbott Diabetes Care Inc.Analyte monitoring and management system and methods therefor
US8089363Jan 3, 2012Abbott Diabetes Care Inc.Method and system for providing data management in data monitoring system
US8100880Jan 24, 2012Velomedix, Inc.Automated therapy system and method
US8103456Jan 24, 2012Abbott Diabetes Care Inc.Method and device for early signal attenuation detection using blood glucose measurements
US8103471May 14, 2008Jan 24, 2012Abbott Diabetes Care Inc.Method and apparatus for providing data processing and control in a medical communication system
US8106534Jan 31, 2012Medtronic Minimed, Inc.Method and apparatus for predicting end of battery life
US8106780Jan 31, 2012Abbott Diabetes Care Inc.Analyte meter including an RFID reader
US8112138Sep 26, 2008Feb 7, 2012Abbott Diabetes Care Inc.Method and apparatus for providing rechargeable power in data monitoring and management systems
US8112240Apr 29, 2005Feb 7, 2012Abbott Diabetes Care Inc.Method and apparatus for providing leak detection in data monitoring and management systems
US8115635Nov 24, 2009Feb 14, 2012Abbott Diabetes Care Inc.RF tag on test strips, test strip vials and boxes
US8116840Oct 30, 2007Feb 14, 2012Abbott Diabetes Care Inc.Method of calibrating of an analyte-measurement device, and associated methods, devices and systems
US8121857Feb 14, 2008Feb 21, 2012Abbott Diabetes Care Inc.Device and method for automatic data acquisition and/or detection
US8123686Mar 1, 2007Feb 28, 2012Abbott Diabetes Care Inc.Method and apparatus for providing rolling data in communication systems
US8135548Oct 26, 2007Mar 13, 2012Abbott Diabetes Care Inc.Method, system and computer program product for real-time detection of sensitivity decline in analyte sensors
US8140142Apr 14, 2008Mar 20, 2012Abbott Diabetes Care Inc.Method and apparatus for providing data processing and control in medical communication system
US8140312Jan 31, 2008Mar 20, 2012Abbott Diabetes Care Inc.Method and system for determining analyte levels
US8149103May 23, 2011Apr 3, 2012Abbott Diabetes Care Inc.Method and apparatus for providing dynamic multi-stage amplification in a medical device
US8149117Aug 29, 2009Apr 3, 2012Abbott Diabetes Care Inc.Analyte monitoring system and methods
US8160900Apr 17, 2012Abbott Diabetes Care Inc.Analyte monitoring and management device and method to analyze the frequency of user interaction with the device
US8162829Mar 30, 2009Apr 24, 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8175673Nov 9, 2009May 8, 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8177716Dec 21, 2009May 15, 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8182692May 28, 2008May 22, 2012Fresenius Medical Care Holdings, Inc.Solutions, dialysates, and related methods
US8185181May 22, 2012Abbott Diabetes Care Inc.Method and apparatus for detecting false hypoglycemic conditions
US8187183Oct 11, 2010May 29, 2012Abbott Diabetes Care Inc.Continuous glucose monitoring system and methods of use
US8197444Dec 22, 2010Jun 12, 2012Medtronic Minimed, Inc.Monitoring the seating status of a fluid reservoir in a fluid infusion device
US8211016Jul 3, 2012Abbott Diabetes Care Inc.Method and system for providing analyte monitoring
US8216137Jul 20, 2009Jul 10, 2012Abbott Diabetes Care Inc.Method and system for providing analyte monitoring
US8216138Jul 10, 2012Abbott Diabetes Care Inc.Correlation of alternative site blood and interstitial fluid glucose concentrations to venous glucose concentration
US8219173Sep 30, 2008Jul 10, 2012Abbott Diabetes Care Inc.Optimizing analyte sensor calibration
US8219174Jun 29, 2009Jul 10, 2012Abbott Diabetes Care Inc.Method of calibrating an analyte-measurement device, and associated methods, devices and systems
US8219175Jun 29, 2009Jul 10, 2012Abbott Diabetes Care Inc.Method of calibrating an analyte-measurement device, and associated methods, devices and systems
US8223021Jul 17, 2012Abbott Diabetes Care Inc.RF tag on test strips, test strip vials and boxes
US8224413Oct 10, 2008Jul 17, 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8224415Jan 29, 2009Jul 17, 2012Abbott Diabetes Care Inc.Method and device for providing offset model based calibration for analyte sensor
US8226555Mar 18, 2009Jul 24, 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8226557Jul 24, 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8226558Sep 27, 2010Jul 24, 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8226891Jul 24, 2012Abbott Diabetes Care Inc.Analyte monitoring devices and methods therefor
US8231532Apr 30, 2007Jul 31, 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8235896Dec 21, 2009Aug 7, 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8236242Feb 12, 2010Aug 7, 2012Abbott Diabetes Care Inc.Blood glucose tracking apparatus and methods
US8239166Aug 7, 2012Abbott Diabetes Care Inc.Method and apparatus for providing data processing and control in a medical communication system
US8251904Aug 28, 2012Roche Diagnostics Operations, Inc.Device and method for insulin dosing
US8252229Apr 10, 2009Aug 28, 2012Abbott Diabetes Care Inc.Method and system for sterilizing an analyte sensor
US8255031Mar 17, 2009Aug 28, 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8260392Sep 4, 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8260558May 14, 2008Sep 4, 2012Abbott Diabetes Care Inc.Method and apparatus for providing data processing and control in a medical communication system
US8265726Sep 11, 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8268243Dec 28, 2009Sep 18, 2012Abbott Diabetes Care Inc.Blood glucose tracking apparatus and methods
US8273022Sep 25, 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8275439Nov 9, 2009Sep 25, 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8287454Oct 16, 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8287495Oct 10, 2011Oct 16, 2012Tandem Diabetes Care, Inc.Infusion pump system with disposable cartridge having pressure venting and pressure feedback
US8298172Apr 7, 2006Oct 30, 2012Novo Nordisk A/SMedical skin mountable device and system
US8298184Oct 30, 2012Tandem Diabetes Care, Inc.Infusion pump system with disposable cartridge having pressure venting and pressure feedback
US8306598Nov 9, 2009Nov 6, 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8333714Sep 10, 2006Dec 18, 2012Abbott Diabetes Care Inc.Method and system for providing an integrated analyte sensor insertion device and data processing unit
US8343092Nov 24, 2009Jan 1, 2013Abbott Diabetes Care Inc.Method and system for providing integrated medication infusion and analyte monitoring system
US8343093May 28, 2010Jan 1, 2013Abbott Diabetes Care Inc.Fluid delivery device with autocalibration
US8344847Jul 9, 2009Jan 1, 2013Medtronic Minimed, Inc.Coordination of control commands in a medical device system having at least one therapy delivery device and at least one wireless controller device
US8344966Jan 31, 2006Jan 1, 2013Abbott Diabetes Care Inc.Method and system for providing a fault tolerant display unit in an electronic device
US8346335Jan 1, 2013Abbott Diabetes Care Inc.Analyte sensor calibration management
US8346336Mar 18, 2009Jan 1, 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8346337Jun 30, 2009Jan 1, 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8353829Dec 21, 2009Jan 15, 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8357091Jan 22, 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8358210Jan 22, 2013Abbott Diabetes Care Inc.RF tag on test strips, test strip vials and boxes
US8362904Jan 29, 2013Abbott Diabetes Care Inc.Analyte monitoring system and methods
US8366614Mar 30, 2009Feb 5, 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8368556Feb 5, 2013Abbott Diabetes Care Inc.Method and system for providing data communication in continuous glucose monitoring and management system
US8372005Dec 21, 2009Feb 12, 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8374668Oct 23, 2008Feb 12, 2013Abbott Diabetes Care Inc.Analyte sensor with lag compensation
US8376945Nov 23, 2009Feb 19, 2013Abbott Diabetes Care Inc.Method and system for providing calibration of an analyte sensor in an analyte monitoring system
US8377031Aug 31, 2008Feb 19, 2013Abbott Diabetes Care Inc.Closed loop control system with safety parameters and methods
US8380273Feb 19, 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8386042Feb 26, 2013Medtronic Minimed, Inc.Omnidirectional accelerometer device and medical device incorporating same
US8390455Mar 5, 2013Abbott Diabetes Care Inc.RF tag on test strips, test strip vials and boxes
US8391945Mar 17, 2009Mar 5, 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8394060Mar 12, 2013Novo Nordisk A/SVented drug reservoir unit
US8409093Apr 2, 2013Abbott Diabetes Care Inc.Assessing measures of glycemic variability
US8409131Mar 7, 2007Apr 2, 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8410939Apr 2, 2013Abbott Diabetes Care Inc.Analyte meter including an RFID reader
US8417311Sep 14, 2009Apr 9, 2013Optiscan Biomedical CorporationFluid component analysis system and method for glucose monitoring and control
US8417545Apr 9, 2013Abbott Diabetes Care Inc.Device and method for automatic data acquisition and/or detection
US8427298Apr 23, 2013Abbott Diabetes Care Inc.Method and apparatus for providing dynamic multi-stage amplification in a medical device
US8439960May 14, 2013Velomedix, Inc.Hypothermia devices and methods
US8444560May 14, 2008May 21, 2013Abbott Diabetes Care Inc.Method and apparatus for providing data processing and control in a medical communication system
US8444623Jun 6, 2011May 21, 2013Plc Medical Systems, Inc.Patient hydration method
US8449524Jun 30, 2011May 28, 2013Optiscan Biomedical CorporationFluid component analysis systems and methods for glucose monitoring and control
US8456301May 8, 2008Jun 4, 2013Abbott Diabetes Care Inc.Analyte monitoring system and methods
US8460243 *Jun 10, 2003Jun 11, 2013Abbott Diabetes Care Inc.Glucose measuring module and insulin pump combination
US8461985May 8, 2008Jun 11, 2013Abbott Diabetes Care Inc.Analyte monitoring system and methods
US8465425Jun 18, 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8467972Jun 18, 2013Abbott Diabetes Care Inc.Closed loop blood glucose control algorithm analysis
US8471714Dec 30, 2011Jun 25, 2013Abbott Diabetes Care Inc.Method and system for providing data management in data monitoring system
US8473021Jul 31, 2009Jun 25, 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8473022Jan 30, 2009Jun 25, 2013Abbott Diabetes Care Inc.Analyte sensor with time lag compensation
US8473220Jan 23, 2012Jun 25, 2013Abbott Diabetes Care Inc.Method and device for early signal attenuation detection using blood glucose measurements
US8474332Oct 20, 2010Jul 2, 2013Medtronic Minimed, Inc.Sensor assembly and medical device incorporating same
US8478557Jul 30, 2010Jul 2, 2013Abbott Diabetes Care Inc.Method and apparatus for providing analyte monitoring system calibration accuracy
US8479595Oct 20, 2010Jul 9, 2013Medtronic Minimed, Inc.Sensor assembly and medical device incorporating same
US8480580Apr 19, 2007Jul 9, 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8480648Jan 19, 2012Jul 9, 2013Velomedix, Inc.Automated therapy system and method
US8483967Apr 28, 2010Jul 9, 2013Abbott Diabetes Care Inc.Method and system for providing real time analyte sensor calibration with retrospective backfill
US8484005Mar 19, 2012Jul 9, 2013Abbott Diabetes Care Inc.Method and system for determining analyte levels
US8487758Sep 2, 2009Jul 16, 2013Medtronic Minimed, Inc.Medical device having an intelligent alerting scheme, and related operating methods
US8495918Oct 20, 2010Jul 30, 2013Medtronic Minimed, Inc.Sensor assembly and medical device incorporating same
US8497777Apr 15, 2010Jul 30, 2013Abbott Diabetes Care Inc.Analyte monitoring system having an alert
US8506482Feb 7, 2011Aug 13, 2013Abbott Diabetes Care Inc.Method and system for providing continuous calibration of implantable analyte sensors
US8509107Nov 1, 2010Aug 13, 2013Abbott Diabetes Care Inc.Close proximity communication device and methods
US8512239 *Apr 20, 2009Aug 20, 2013Abbott Diabetes Care Inc.Glucose measuring device for use in personal area network
US8512243Sep 30, 2005Aug 20, 2013Abbott Diabetes Care Inc.Integrated introducer and transmitter assembly and methods of use
US8512246Mar 15, 2010Aug 20, 2013Abbott Diabetes Care Inc.Method and apparatus for providing peak detection circuitry for data communication systems
US8514086Aug 30, 2010Aug 20, 2013Abbott Diabetes Care Inc.Displays for a medical device
US8515517Sep 30, 2009Aug 20, 2013Abbott Diabetes Care Inc.Method and system for dynamically updating calibration parameters for an analyte sensor
US8523803Mar 20, 2012Sep 3, 2013Medtronic Minimed, Inc.Motor health monitoring and medical device incorporating same
US8527208Nov 17, 2008Sep 3, 2013Roche Diagnostics International AgPrandial blood glucose excursion optimization method via computation of time-varying optimal insulin profiles and system thereof
US8532935Jul 16, 2012Sep 10, 2013Abbott Diabetes Care Inc.Method and device for providing offset model based calibration for analyte sensor
US8542122Jan 17, 2013Sep 24, 2013Abbott Diabetes Care Inc.Glucose measurement device and methods using RFID
US8543183Dec 23, 2011Sep 24, 2013Abbott Diabetes Care Inc.Analyte monitoring and management system and methods therefor
US8545403Dec 28, 2006Oct 1, 2013Abbott Diabetes Care Inc.Medical device insertion
US8560038May 14, 2008Oct 15, 2013Abbott Diabetes Care Inc.Method and apparatus for providing data processing and control in a medical communication system
US8560082Jan 30, 2009Oct 15, 2013Abbott Diabetes Care Inc.Computerized determination of insulin pump therapy parameters using real time and retrospective data processing
US8562565Oct 15, 2010Oct 22, 2013Medtronic Minimed, Inc.Battery shock absorber for a portable medical device
US8564447Mar 18, 2011Oct 22, 2013Medtronic Minimed, Inc.Battery life indication techniques for an electronic device
US8571624Dec 29, 2004Oct 29, 2013Abbott Diabetes Care Inc.Method and apparatus for mounting a data transmission device in a communication system
US8571808Jan 23, 2012Oct 29, 2013Abbott Diabetes Care Inc.Method and apparatus for providing data processing and control in a medical communication system
US8574201Dec 17, 2010Nov 5, 2013Medtronic Minimed, Inc.Syringe piston with check valve seal
US8579853Oct 31, 2006Nov 12, 2013Abbott Diabetes Care Inc.Infusion devices and methods
US8583205Apr 16, 2010Nov 12, 2013Abbott Diabetes Care Inc.Analyte sensor calibration management
US8585591Jul 10, 2010Nov 19, 2013Abbott Diabetes Care Inc.Method and system for providing basal profile modification in analyte monitoring and management systems
US8591410Jun 1, 2009Nov 26, 2013Abbott Diabetes Care Inc.Method and apparatus for providing glycemic control
US8593109Nov 3, 2009Nov 26, 2013Abbott Diabetes Care Inc.Method and system for powering an electronic device
US8593287Jul 20, 2012Nov 26, 2013Abbott Diabetes Care Inc.Analyte monitoring system and methods
US8597188Jun 20, 2008Dec 3, 2013Abbott Diabetes Care Inc.Health management devices and methods
US8597189Mar 3, 2009Dec 3, 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8597575Jul 23, 2012Dec 3, 2013Abbott Diabetes Care Inc.Analyte monitoring devices and methods therefor
US8600681May 14, 2008Dec 3, 2013Abbott Diabetes Care Inc.Method and apparatus for providing data processing and control in a medical communication system
US8602991Jun 7, 2010Dec 10, 2013Abbott Diabetes Care Inc.Analyte sensor introducer and methods of use
US8603026Mar 20, 2012Dec 10, 2013Medtronic Minimed, Inc.Dynamic pulse-width modulation motor control and medical device incorporating same
US8603027Mar 20, 2012Dec 10, 2013Medtronic Minimed, Inc.Occlusion detection using pulse-width modulation and medical device incorporating same
US8603032Oct 15, 2010Dec 10, 2013Medtronic Minimed, Inc.Medical device with membrane keypad sealing element, and related manufacturing method
US8603033Oct 15, 2010Dec 10, 2013Medtronic Minimed, Inc.Medical device and related assembly having an offset element for a piezoelectric speaker
US8612159Feb 16, 2004Dec 17, 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8612163Aug 30, 2012Dec 17, 2013Abbott Diabetes Care Inc.Method and apparatus for providing data processing and control in a medical communication system
US8613703May 29, 2008Dec 24, 2013Abbott Diabetes Care Inc.Insertion devices and methods
US8613892Jun 30, 2009Dec 24, 2013Abbott Diabetes Care Inc.Analyte meter with a moveable head and methods of using the same
US8614596Feb 28, 2011Dec 24, 2013Medtronic Minimed, Inc.Systems and methods for initializing a voltage bus and medical devices incorporating same
US8617069Jun 20, 2008Dec 31, 2013Abbott Diabetes Care Inc.Health monitor
US8617071Jun 21, 2007Dec 31, 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8622903May 25, 2012Jan 7, 2014Abbott Diabetes Care Inc.Continuous glucose monitoring system and methods of use
US8622906Dec 21, 2009Jan 7, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8622954Apr 28, 2010Jan 7, 2014Medtronic Minimed, Inc.Relay device for transferring information between a sensor system and a fluid delivery system
US8622988Aug 31, 2008Jan 7, 2014Abbott Diabetes Care Inc.Variable rate closed loop control and methods
US8628510Dec 22, 2010Jan 14, 2014Medtronic Minimed, Inc.Monitoring the operating health of a force sensor in a fluid infusion device
US8635046Jun 22, 2011Jan 21, 2014Abbott Diabetes Care Inc.Method and system for evaluating analyte sensor response characteristics
US8638220May 23, 2011Jan 28, 2014Abbott Diabetes Care Inc.Method and apparatus for providing data communication in data monitoring and management systems
US8641619Dec 21, 2009Feb 4, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8647269Apr 20, 2009Feb 11, 2014Abbott Diabetes Care Inc.Glucose measuring device for use in personal area network
US8649841Apr 3, 2007Feb 11, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8652043Jul 20, 2012Feb 18, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8653977Jun 21, 2013Feb 18, 2014Abbott Diabetes Care Inc.Method and system for providing data management in data monitoring system
US8660627Mar 17, 2009Feb 25, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8663201Sep 20, 2011Mar 4, 2014Medtronic Minimed, Inc.Infusion device
US8665091Jun 30, 2009Mar 4, 2014Abbott Diabetes Care Inc.Method and device for determining elapsed sensor life
US8666469Nov 16, 2007Mar 4, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8668645Jan 3, 2003Mar 11, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8670815Apr 30, 2007Mar 11, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8672844Feb 27, 2004Mar 18, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8672884Oct 23, 2006Mar 18, 2014Velomedix, Inc.Method and apparatus for peritoneal hypothermia and/or resuscitation
US8676513Jun 21, 2013Mar 18, 2014Abbott Diabetes Care Inc.Method and device for early signal attenuation detection using blood glucose measurements
US8676601Apr 8, 2013Mar 18, 2014Abbott Diabetes Care Inc.Device and method for automatic data acquisition and/or detection
US8682615Aug 4, 2012Mar 25, 2014Abbott Diabetes Care Inc.Method and apparatus for providing data processing and control in a medical communication system
US8684930Jun 29, 2009Apr 1, 2014Abbott Diabetes Care Inc.Method of calibrating an analyte-measurement device, and associated methods, devices and systems
US8688188Jun 30, 2009Apr 1, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8690769Apr 21, 2009Apr 8, 2014Philometron, Inc.Metabolic energy monitoring system
US8690855 *Jun 20, 2012Apr 8, 2014Medtronic Minimed, Inc.Fluid reservoir seating procedure for a fluid infusion device
US8698615Apr 22, 2013Apr 15, 2014Abbott Diabetes Care Inc.Method and apparatus for providing dynamic multi-stage signal amplification in a medical device
US8710993Nov 21, 2012Apr 29, 2014Abbott Diabetes Care Inc.Mitigating single point failure of devices in an analyte monitoring system and methods thereof
US8718739Dec 28, 2012May 6, 2014Abbott Diabetes Care Inc.Analyte sensor calibration management
US8718958Mar 12, 2012May 6, 2014Abbott Diabetes Care Inc.Method, system and computer program product for real-time detection of sensitivity decline in analyte sensors
US8718965Jun 24, 2013May 6, 2014Abbott Diabetes Care Inc.Method and apparatus for providing analyte monitoring system calibration accuracy
US8730058Jul 29, 2013May 20, 2014Abbott Diabetes Care Inc.Analyte monitoring system having an alert
US8732188Feb 15, 2008May 20, 2014Abbott Diabetes Care Inc.Method and system for providing contextual based medication dosage determination
US8734344May 29, 2011May 27, 2014Abbott Diabetes Care Inc.On-body medical device securement
US8734346Apr 30, 2007May 27, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8734348Mar 17, 2009May 27, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8734422Aug 31, 2008May 27, 2014Abbott Diabetes Care Inc.Closed loop control with improved alarm functions
US8737259Aug 5, 2013May 27, 2014Abbott Diabetes Care Inc.Close proximity communication device and methods
US8738109Mar 3, 2009May 27, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8744545Mar 3, 2009Jun 3, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8744547Jul 9, 2012Jun 3, 2014Abbott Diabetes Care Inc.Optimizing analyte sensor calibration
US8747363Sep 25, 2012Jun 10, 2014Novo Nordisk A/SMedical skin mountable device and system
US8755269Dec 23, 2009Jun 17, 2014Medtronic Minimed, Inc.Ranking and switching of wireless channels in a body area network of medical devices
US8758240 *Dec 11, 2006Jun 24, 2014Roche Diagnostics International AgSystem with a portable patient device and external operating part
US8758323Jul 29, 2010Jun 24, 2014Tandem Diabetes Care, Inc.Infusion pump system with disposable cartridge having pressure venting and pressure feedback
US8760297Mar 28, 2013Jun 24, 2014Abbott Diabetes Care Inc.Analyte meter including an RFID reader
US8764657Mar 30, 2012Jul 1, 2014Abbott Diabetes Care Inc.Medical device inserters and processes of inserting and using medical devices
US8765059Oct 27, 2010Jul 1, 2014Abbott Diabetes Care Inc.Blood glucose tracking apparatus
US8771183Feb 16, 2005Jul 8, 2014Abbott Diabetes Care Inc.Method and system for providing data communication in continuous glucose monitoring and management system
US8774887Mar 24, 2007Jul 8, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8783102 *Dec 17, 2010Jul 22, 2014Roche Diagnostics Operations, Inc.Protective container for holding reusable diagnostic components
US8795252Oct 16, 2009Aug 5, 2014Abbott Diabetes Care Inc.Robust closed loop control and methods
US8798934Jul 23, 2010Aug 5, 2014Abbott Diabetes Care Inc.Real time management of data relating to physiological control of glucose levels
US8802006Aug 27, 2012Aug 12, 2014Abbott Diabetes Care Inc.Method and system for sterilizing an analyte sensor
US8808269Aug 21, 2012Aug 19, 2014Medtronic Minimed, Inc.Reservoir plunger position monitoring and medical device incorporating same
US8816862Aug 19, 2013Aug 26, 2014Abbott Diabetes Care Inc.Displays for a medical device
US8834366Jul 31, 2007Sep 16, 2014Abbott Diabetes Care Inc.Method and apparatus for providing analyte sensor calibration
US8840553Feb 26, 2009Sep 23, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8852101Sep 30, 2009Oct 7, 2014Abbott Diabetes Care Inc.Method and apparatus for providing analyte sensor insertion
US8862198Dec 17, 2012Oct 14, 2014Abbott Diabetes Care Inc.Method and system for providing an integrated analyte sensor insertion device and data processing unit
US8864726Feb 17, 2012Oct 21, 2014Medtronic Minimed, Inc.Pressure vented fluid reservoir having a movable septum
US8870811Aug 31, 2006Oct 28, 2014Fresenius Medical Care Holdings, Inc.Peritoneal dialysis systems and related methods
US8870818Nov 15, 2012Oct 28, 2014Medtronic Minimed, Inc.Systems and methods for alignment and detection of a consumable component
US8870829Feb 17, 2012Oct 28, 2014Medtronic Minimed, Inc.Fluid infusion device and related sealing assembly for a needleless fluid reservoir
US8876755Jul 14, 2009Nov 4, 2014Abbott Diabetes Care Inc.Closed loop control system interface and methods
US8880137Apr 18, 2003Nov 4, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8880138Sep 30, 2005Nov 4, 2014Abbott Diabetes Care Inc.Device for channeling fluid and methods of use
US8900206Feb 17, 2012Dec 2, 2014Medtronic Minimed, Inc.Pressure vented fluid reservoir for a fluid infusion device
US8915850Mar 28, 2014Dec 23, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8920319Dec 28, 2012Dec 30, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8920381Apr 12, 2013Dec 30, 2014Medtronic Minimed, Inc.Infusion set with improved bore configuration
US8924159Jun 1, 2009Dec 30, 2014Abbott Diabetes Care Inc.Method and apparatus for providing glycemic control
US8926550 *Aug 31, 2006Jan 6, 2015Fresenius Medical Care Holdings, Inc.Data communication system for peritoneal dialysis machine
US8926561Jul 29, 2010Jan 6, 2015Tandem Diabetes Care, Inc.Infusion pump system with disposable cartridge having pressure venting and pressure feedback
US8930203Feb 3, 2010Jan 6, 2015Abbott Diabetes Care Inc.Multi-function analyte test device and methods therefor
US8933664Nov 25, 2013Jan 13, 2015Abbott Diabetes Care Inc.Method and system for powering an electronic device
US8937540Feb 24, 2014Jan 20, 2015Abbott Diabetes Care Inc.Method and apparatus for providing dynamic multi-stage signal amplification in a medical device
US8945068Feb 17, 2012Feb 3, 2015Medtronic Minimed, Inc.Fluid reservoir having a fluid delivery needle for a fluid infusion device
US8974386Nov 1, 2005Mar 10, 2015Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US8986208Sep 30, 2008Mar 24, 2015Abbott Diabetes Care Inc.Analyte sensor sensitivity attenuation mitigation
US8986253Aug 7, 2009Mar 24, 2015Tandem Diabetes Care, Inc.Two chamber pumps and related methods
US8993331Aug 31, 2010Mar 31, 2015Abbott Diabetes Care Inc.Analyte monitoring system and methods for managing power and noise
US9000929Nov 22, 2013Apr 7, 2015Abbott Diabetes Care Inc.Analyte monitoring system and methods
US9008743Apr 14, 2008Apr 14, 2015Abbott Diabetes Care Inc.Method and apparatus for providing data processing and control in medical communication system
US9011331Dec 29, 2004Apr 21, 2015Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US9011332Oct 30, 2007Apr 21, 2015Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US9014773Mar 7, 2007Apr 21, 2015Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US9018893Mar 18, 2011Apr 28, 2015Medtronic Minimed, Inc.Power control techniques for an electronic device
US9020572 *Sep 10, 2010Apr 28, 2015Dexcom, Inc.Systems and methods for processing, transmitting and displaying sensor data
US9031630Nov 1, 2010May 12, 2015Abbott Diabetes Care Inc.Analyte sensors and methods of use
US9033924Jan 18, 2013May 19, 2015Medtronic Minimed, Inc.Systems for fluid reservoir retention
US9035767May 30, 2013May 19, 2015Abbott Diabetes Care Inc.Analyte monitoring system and methods
US9039975Dec 2, 2013May 26, 2015Abbott Diabetes Care Inc.Analyte monitoring devices and methods therefor
US9042953Mar 2, 2007May 26, 2015Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US9050041May 21, 2012Jun 9, 2015Abbott Diabetes Care Inc.Method and apparatus for detecting false hypoglycemic conditions
US9060719Dec 13, 2013Jun 23, 2015Abbott Diabetes Care Inc.Method and apparatus for providing data processing and control in a medical communication system
US9060805Jun 24, 2014Jun 23, 2015Abbott Diabetes Care Inc.Analyte meter including an RFID reader
US9064107Sep 30, 2013Jun 23, 2015Abbott Diabetes Care Inc.Infusion devices and methods
US9066694Apr 3, 2007Jun 30, 2015Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US9066695Apr 12, 2007Jun 30, 2015Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US9066697Oct 27, 2011Jun 30, 2015Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US9066709Mar 17, 2014Jun 30, 2015Abbott Diabetes Care Inc.Method and device for early signal attenuation detection using blood glucose measurements
US9069536Oct 30, 2012Jun 30, 2015Abbott Diabetes Care Inc.Electronic devices having integrated reset systems and methods thereof
US9072425 *Mar 4, 2014Jul 7, 2015Stuart BogemaMethod of providing a proper on-site evidence chain for a combined drug test/DNA preservation protocol
US9072477Jun 21, 2007Jul 7, 2015Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US9078607Jun 17, 2013Jul 14, 2015Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US9088452Jan 31, 2013Jul 21, 2015Abbott Diabetes Care Inc.Method and system for providing data communication in continuous glucose monitoring and management system
US9095290Feb 27, 2012Aug 4, 2015Abbott Diabetes Care Inc.Method and apparatus for providing rolling data in communication systems
US9101305Mar 9, 2011Aug 11, 2015Medtronic Minimed, Inc.Glucose sensor product and related manufacturing and packaging methods
US9107994Jan 18, 2013Aug 18, 2015Medtronic Minimed, Inc.Systems for fluid reservoir retention
US9113828Jul 9, 2012Aug 25, 2015Abbott Diabetes Care Inc.Method and system for providing analyte monitoring
US9125548May 14, 2008Sep 8, 2015Abbott Diabetes Care Inc.Method and apparatus for providing data processing and control in a medical communication system
US9143569 *Feb 20, 2009Sep 22, 2015Dexcom, Inc.Systems and methods for processing, transmitting and displaying sensor data
US9177456Jun 10, 2013Nov 3, 2015Abbott Diabetes Care Inc.Analyte monitoring system and methods
US9178752Apr 25, 2014Nov 3, 2015Abbott Diabetes Care Inc.Analyte monitoring system having an alert
US9180243Mar 15, 2013Nov 10, 2015Tandem Diabetes Care, Inc.Detection of infusion pump conditions
US9184875Apr 25, 2014Nov 10, 2015Abbott Diabetes Care, Inc.Close proximity communication device and methods
US9186098Mar 24, 2011Nov 17, 2015Abbott Diabetes Care Inc.Medical device inserters and processes of inserting and using medical devices
US9186113Aug 11, 2014Nov 17, 2015Abbott Diabetes Care Inc.Displays for a medical device
US9204827Apr 14, 2008Dec 8, 2015Abbott Diabetes Care Inc.Method and apparatus for providing data processing and control in medical communication system
US9211377Jul 29, 2010Dec 15, 2015Tandem Diabetes Care, Inc.Infusion pump system with disposable cartridge having pressure venting and pressure feedback
US9215992Mar 24, 2011Dec 22, 2015Abbott Diabetes Care Inc.Medical device inserters and processes of inserting and using medical devices
US9226701Apr 28, 2010Jan 5, 2016Abbott Diabetes Care Inc.Error detection in critical repeating data in a wireless sensor system
US9226714Jan 8, 2015Jan 5, 2016Abbott Diabetes Care Inc.Displays for a medical device
US9259175Oct 23, 2006Feb 16, 2016Abbott Diabetes Care, Inc.Flexible patch for fluid delivery and monitoring body analytes
US9259528Aug 22, 2013Feb 16, 2016Medtronic Minimed, Inc.Fluid infusion device with safety coupling
US9265453Mar 24, 2011Feb 23, 2016Abbott Diabetes Care Inc.Medical device inserters and processes of inserting and using medical devices
US9272125Feb 17, 2012Mar 1, 2016Medtronic Minimed, Inc.Sealing assembly for a fluid reservoir of a fluid infusion device
US9289179Apr 11, 2014Mar 22, 2016Abbott Diabetes Care Inc.Mitigating single point failure of devices in an analyte monitoring system and methods thereof
US9302045Apr 5, 2013Apr 5, 2016Optiscan Biomedical CorporationFluid component analysis system and method for glucose monitoring and control
US9308321Feb 18, 2013Apr 12, 2016Medtronic Minimed, Inc.Infusion device having gear assembly initialization
US9310230Jun 24, 2013Apr 12, 2016Abbott Diabetes Care Inc.Method and system for providing real time analyte sensor calibration with retrospective backfill
US9314195Aug 31, 2010Apr 19, 2016Abbott Diabetes Care Inc.Analyte signal processing device and methods
US9314198Apr 3, 2015Apr 19, 2016Abbott Diabetes Care Inc.Analyte monitoring system and methods
US9317656Nov 21, 2012Apr 19, 2016Abbott Diabetes Care Inc.Compatibility mechanisms for devices in a continuous analyte monitoring system and methods thereof
US9320461Sep 29, 2010Apr 26, 2016Abbott Diabetes Care Inc.Method and apparatus for providing notification function in analyte monitoring systems
US9320462May 5, 2014Apr 26, 2016Abbott Diabetes Care Inc.Analyte sensor calibration management
US9320468Jun 21, 2013Apr 26, 2016Abbott Diabetes Care Inc.Analyte sensor with time lag compensation
US9323898Nov 15, 2013Apr 26, 2016Abbott Diabetes Care Inc.Method and system for providing basal profile modification in analyte monitoring and management systems
US9326707Nov 10, 2009May 3, 2016Abbott Diabetes Care Inc.Alarm characterization for analyte monitoring devices and systems
US9326709Mar 9, 2011May 3, 2016Abbott Diabetes Care Inc.Systems, devices and methods for managing glucose levels
US9326714Jun 29, 2010May 3, 2016Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US9326716Dec 5, 2014May 3, 2016Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US9326727May 15, 2014May 3, 2016Abbott Diabetes Care Inc.On-body medical device securement
US9332933Sep 29, 2014May 10, 2016Abbott Diabetes Care Inc.Method and apparatus for providing analyte sensor insertion
US9332934Feb 8, 2013May 10, 2016Abbott Diabetes Care Inc.Analyte sensor with lag compensation
US9332944Jan 31, 2014May 10, 2016Abbott Diabetes Care Inc.Method and system for providing data management in data monitoring system
US9333292Jun 26, 2012May 10, 2016Medtronic Minimed, Inc.Mechanically actuated fluid infusion device
US9336423Jun 22, 2015May 10, 2016Abbott Diabetes Care Inc.Analyte meter including an RFID reader
US9339217Nov 21, 2012May 17, 2016Abbott Diabetes Care Inc.Analyte monitoring system and methods of use
US9339639Feb 17, 2012May 17, 2016Medtronic Minimed, Inc.Sealing assembly for a fluid reservoir of a fluid infusion device
US9344024Nov 1, 2013May 17, 2016Medtronic Minimed, Inc.Occlusion detection using pulse-width modulation and medical device incorporating same
US9351669Sep 30, 2010May 31, 2016Abbott Diabetes Care Inc.Interconnect for on-body analyte monitoring device
US9357959Aug 19, 2013Jun 7, 2016Abbott Diabetes Care Inc.Method and system for dynamically updating calibration parameters for an analyte sensor
US9364149Oct 3, 2011Jun 14, 2016Abbott Diabetes Care Inc.Analyte sensor transmitter unit configuration for a data monitoring and management system
US9364609Apr 25, 2013Jun 14, 2016Medtronic Minimed, Inc.Insulin on board compensation for a closed-loop insulin infusion system
US9379652Jul 18, 2013Jun 28, 2016Medtronic Minimed, Inc.Motor health monitoring and medical device incorporating same
US9379653Nov 1, 2013Jun 28, 2016Medtronic Minimed, Inc.Dynamic pulse-width modulation motor control and medical device incorporating same
US9380971Dec 5, 2014Jul 5, 2016Abbott Diabetes Care Inc.Method and system for powering an electronic device
US9392969Aug 31, 2008Jul 19, 2016Abbott Diabetes Care Inc.Closed loop control and signal attenuation detection
US9393399Aug 30, 2012Jul 19, 2016Medtronic Minimed, Inc.Sealing assembly for a fluid reservoir of a fluid infusion device
US9398872Aug 28, 2014Jul 26, 2016Abbott Diabetes Care Inc.Method and apparatus for providing analyte sensor calibration
US9398882Sep 10, 2006Jul 26, 2016Abbott Diabetes Care Inc.Method and apparatus for providing analyte sensor and data processing device
US9399096Feb 6, 2014Jul 26, 2016Medtronic Minimed, Inc.Automatic closed-loop control adjustments and infusion systems incorporating same
US9402544Feb 1, 2010Aug 2, 2016Abbott Diabetes Care Inc.Analyte sensor and apparatus for insertion of the sensor
US9402570Dec 11, 2012Aug 2, 2016Abbott Diabetes Care Inc.Analyte sensor devices, connections, and methods
US9402584Jan 14, 2015Aug 2, 2016Abbott Diabetes Care Inc.Method and apparatus for providing dynamic multi-stage signal amplification in a medical device
US9402949Aug 13, 2013Aug 2, 2016Medtronic Minimed, Inc.Detecting conditions associated with medical device operations using matched filters
US9408566Feb 13, 2013Aug 9, 2016Abbott Diabetes Care Inc.Method and system for providing calibration of an analyte sensor in an analyte monitoring system
US20040215492 *May 24, 2004Oct 28, 2004Choi Soo BongMethod for controlling insulin pump through internet
US20050151661 *Dec 14, 2004Jul 14, 2005Albarado Jason P.Enclosure system for hot work within the vicinity of flammable or combustible material
US20060010098 *Jun 6, 2005Jan 12, 2006Goodnow Timothy TDiabetes care host-client architecture and data management system
US20060226985 *Feb 7, 2006Oct 12, 2006Goodnow Timothy TRF tag on test strips, test strip vials and boxes
US20060264835 *Apr 25, 2006Nov 23, 2006Novo Nordisk A/SMedical skin mountable device
US20070032891 *Oct 10, 2006Feb 8, 2007Choi Soo BMethod for controlling insulin pump through internet
US20070052543 *Jul 7, 2005Mar 8, 2007Albarado Jason PEnclosure system allowing for hot work within the vicinity of flammable and combustible material
US20070060869 *Aug 16, 2005Mar 15, 2007Tolle Mike C VController device for an infusion pump
US20070088333 *Oct 13, 2006Apr 19, 2007G&L Consulting, LlcMethod and system for infusing an osmotic solute into a patient and providing feedback control of the infusing rate
US20070106247 *Oct 23, 2006May 10, 2007Ceeben Systems, Inc.Method and apparatus for peritoneal hypothermia and/or resuscitation
US20070120695 *Nov 29, 2006May 31, 2007Albarado Jason PEnclosure system allowing for hot work within the vicinity of flammable and combustible material
US20070142767 *Dec 11, 2006Jun 21, 2007Marcel FrikartSystem with A Portable Patient Device and External Operating Part
US20070253021 *Feb 5, 2007Nov 1, 2007Medtronic Minimed, Inc.Identification of devices in a medical device network and wireless data communication techniques utilizing device identifiers
US20070255126 *Apr 28, 2006Nov 1, 2007Moberg Sheldon BData communication in networked fluid infusion systems
US20070258395 *Feb 5, 2007Nov 8, 2007Medtronic Minimed, Inc.Wireless data communication protocols for a medical device network
US20070260174 *May 5, 2006Nov 8, 2007Searete LlcDetecting a failure to maintain a regimen
US20070276545 *Apr 28, 2006Nov 29, 2007Smirnov Alexei VAdaptive response time closed loop control algorithm
US20080097283 *Aug 31, 2006Apr 24, 2008Plahey Kulwinder SData communication system for peritoneal dialysis machine
US20080125693 *Aug 31, 2006May 29, 2008Gavin David APeritoneal dialysis systems and related methods
US20080200802 *Dec 7, 2007Aug 21, 2008Philometron, Inc.Platform for detection of tissue content and/or structural changes with closed-loop control in mammalian organisms
US20080214919 *Dec 12, 2007Sep 4, 2008Lifescan, Inc.System and method for implementation of glycemic control protocols
US20080221512 *May 20, 2008Sep 11, 2008Da Silva J RicardoPatient hydration system with taper down feature
US20080234556 *Mar 20, 2007Sep 25, 2008Cardiac Pacemakers, Inc.Method and apparatus for sensing respiratory activities using sensor in lymphatic system
US20080249467 *Apr 4, 2008Oct 9, 2008Daniel Rogers BurnettDevice and Method for Safe Access to a Body Cavity
US20080262418 *Apr 4, 2008Oct 23, 2008Daniel Rogers BurnettAutomated Therapy System and Method
US20080287870 *Oct 17, 2006Nov 20, 2008Nov Nordisk A/SVented Drug Reservoir Unit
US20080296226 *May 28, 2008Dec 4, 2008Fresenius Medical Care Holdings, Inc.Solutions, Dialysates, and Related Methods
US20090048501 *Jul 14, 2004Feb 19, 2009Therasense, Inc.Glucose measuring device integrated into a holster for a personal area network device
US20090118682 *Sep 13, 2006May 7, 2009Novo Nordisk A/SReservoir Device With Inspection Aid For Detection Of Drug Condition
US20090131860 *Apr 7, 2006May 21, 2009Novo Nordisk A/SMedical Skin Mountable Device And System
US20090157202 *Aug 11, 2008Jun 18, 2009Smiths Medical MdTherapy rules for closed loop programming of medical devices
US20090227855 *Dec 23, 2008Sep 10, 2009Medtronic Minimed, Inc.Controller device for an infusion pump
US20090240120 *Feb 20, 2009Sep 24, 2009Dexcom, Inc.Systems and methods for processing, transmitting and displaying sensor data
US20090281518 *Sep 4, 2007Nov 12, 2009Koninklijke Philips Electronics N.V.Device for automatic adjustment of the dose of melatonin and/or delivery of melatonin
US20090284372 *Nov 19, 2009Abbott Diabetes Care Inc.Glucose Measuring Device For Use In Personal Area Network
US20100049004 *Feb 25, 2010Philometron, Inc.Metabolic energy monitoring system
US20100063374 *Mar 11, 2010Goodnow Timothy TAnalyte meter including an RFID reader
US20100100048 *Oct 14, 2009Apr 22, 2010Novo Nordisk A/SMedical Skin Mountable Device
US20100125241 *Nov 17, 2008May 20, 2010Disetronic Licensing, AgPrandial Blood Glucose Excursion Optimization Method Via Computation of Time-Varying Optimal Insulin Profiles and System Thereof
US20100201196 *Apr 27, 2010Aug 12, 2010Medtronic Minimed, Inc.Method and apparatus for predicting end of battery life
US20100204677 *Apr 13, 2010Aug 12, 2010Mark GelfandPatient hydration system and method
US20100234797 *Sep 16, 2010Mark GelfandPatient hydration system with bolus function
US20100274217 *Jan 14, 2010Oct 28, 2010Da Silva J RicardoFluid replacement device
US20100280442 *Apr 28, 2010Nov 4, 2010Medtronic Minimed, Inc.Replay device for transferring information between a sensor system and a fluid delivery system
US20100280443 *Nov 4, 2010Mark GelfandPatient hydration system with redundant monitoring
US20100280444 *May 20, 2010Nov 4, 2010Mark GelfandPatient hydration system with abnormal reading detection
US20100280445 *Nov 4, 2010Mark GelfandPatient hydration system with taper down function
US20100331657 *Sep 10, 2010Dec 30, 2010Dexcom, Inc.Systems and methods for processing, transmitting and displaying sensor data
US20110046547 *Feb 24, 2011Mantle Ross EDevice for the Extravascular Recirculation of Liquid in Body Cavities
US20110137255 *Jun 9, 2011Novo Nordisk A/SMedical Skin Mountable Device
US20110152644 *Jun 23, 2011Wolfgang HeckProtective container for holding reusable diagnostic components
US20110152770 *Jun 23, 2011Tandem Diabetes Care, Inc.Infusion pump system with disposable cartridge having pressure venting and pressure feedback
US20110152824 *Jun 23, 2011Tandem Diabetes Care, Inc.Infusion pump system with disposable cartridge having pressure venting and pressure feedback
US20110160670 *Jun 30, 2011Novo Nordisk A/SVented drug reservoir unit
US20110184653 *Jul 28, 2011Lifescan, Inc.Analyte testing method and system
US20130331961 *Jun 11, 2012Dec 12, 2013General Electric CompanyData exchange system providing flexible and robust handling of units of measure
US20140039383 *Oct 9, 2007Feb 6, 2014Dexcom, Inc.Integrated insulin delivery system with continuous glucose sensor
US20140052095 *Oct 25, 2013Feb 20, 2014Dexcom, Inc.Integrated insulin delivery system with continuous glucose sensor
US20140114278 *Dec 30, 2013Apr 24, 2014Dexcom, Inc.Integrated insulin delivery system with continuous glucose sensor
US20140128803 *Dec 30, 2013May 8, 2014Dexcom, Inc.Integrated insulin delivery system with continuous glucose sensor
CN101856525A *Jun 7, 2010Oct 13, 2010包金明;芮成胜Medical infusion liquid drop speed monitoring method and device
EP2059277B1Aug 29, 2007Aug 19, 2015Fresenius Medical Care Holdings, Inc.Data communication system for peritoneal dialysis machine
EP2990065A1 *Aug 29, 2007Mar 2, 2016Fresenius Medical Care Holdings, Inc.Data communication system for peritoneal dialysis machine
WO2006102412A3 *Mar 21, 2006Nov 22, 2007Abbott Diabetes Care IncMethod and system for providing integrated medication infusion and analyte monitoring system
WO2007127897A2 *Apr 27, 2007Nov 8, 2007Advanced Energy Industries, Inc.Adaptive response time closed loop control algorithm
WO2007127897A3 *Apr 27, 2007Sep 18, 2008Advanced Energy Ind IncAdaptive response time closed loop control algorithm
WO2008027967A1 *Aug 29, 2007Mar 6, 2008Fresenius Medical Care Holdings, Inc.Data communication system for peritoneal dialysis machine
WO2008032238A2 *Sep 4, 2007Mar 20, 2008Koninklijke Philips Electronics N. V.Device for automatic adjustment of the dose of melatonin and/or delivery of melatonin
WO2008032238A3 *Sep 4, 2007Nov 6, 2008Paul A J AckermansDevice for automatic adjustment of the dose of melatonin and/or delivery of melatonin
WO2008124644A1 *Apr 4, 2008Oct 16, 2008Velomedix, IncAutomated therapy system and method
WO2009082741A2 *Dec 22, 2008Jul 2, 2009Medtronic Minimed, Inc.Handling of failure of signal reception of a glucose sensor signal at an external infusion device
WO2009082741A3 *Dec 22, 2008Nov 5, 2009Medtronic Minimed, Inc.Handling of failure of signal reception of a glucose sensor signal at an external infusion device
WO2010089304A1 *Feb 3, 2010Aug 12, 2010Sanofi-Aventis Deutschland GmbhMedical device and method for providing information for glycemic control
Classifications
U.S. Classification604/65, 700/282, 128/920
International ClassificationA61M5/14, A61M5/172, A61M5/142, G06F19/00
Cooperative ClassificationG06F19/3468, A61M2005/1405, A61M2205/3507, A61M2005/14208, A61M2205/3523, A61M5/14276, A61M5/1723
European ClassificationG06F19/34L, A61M5/172B, A61M5/142P10
Legal Events
DateCodeEventDescription
May 8, 2003ASAssignment
Owner name: MEDTRONIC MINIMED, INC., CALIFORNIA
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:SHAHMIRIAN, VARAZ;MORGAN, WAYNE A.;MOBERG, SHELDON B.;AND OTHERS;REEL/FRAME:014060/0434;SIGNING DATES FROM 20020417 TO 20030505